CA2327332A1 - Novel process - Google Patents
Novel process Download PDFInfo
- Publication number
- CA2327332A1 CA2327332A1 CA002327332A CA2327332A CA2327332A1 CA 2327332 A1 CA2327332 A1 CA 2327332A1 CA 002327332 A CA002327332 A CA 002327332A CA 2327332 A CA2327332 A CA 2327332A CA 2327332 A1 CA2327332 A1 CA 2327332A1
- Authority
- CA
- Canada
- Prior art keywords
- formula
- compound
- flask
- reaction mixture
- ether
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 44
- 230000008569 process Effects 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims description 29
- 125000006239 protecting group Chemical group 0.000 claims description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- 238000010168 coupling process Methods 0.000 claims description 7
- 230000009467 reduction Effects 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 claims description 4
- 238000005984 hydrogenation reaction Methods 0.000 claims description 4
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 3
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 3
- 230000008878 coupling Effects 0.000 claims description 2
- -1 prostaglandin compounds Chemical class 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 61
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 59
- 239000011541 reaction mixture Substances 0.000 description 39
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 32
- 235000019439 ethyl acetate Nutrition 0.000 description 29
- 238000006243 chemical reaction Methods 0.000 description 28
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- 239000000243 solution Substances 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 239000000047 product Substances 0.000 description 20
- 239000002904 solvent Substances 0.000 description 19
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 238000003756 stirring Methods 0.000 description 17
- 239000010410 layer Substances 0.000 description 16
- 229910052757 nitrogen Inorganic materials 0.000 description 14
- 238000005160 1H NMR spectroscopy Methods 0.000 description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- 238000003760 magnetic stirring Methods 0.000 description 11
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 10
- 150000003180 prostaglandins Chemical class 0.000 description 10
- 150000002148 esters Chemical class 0.000 description 9
- 239000003039 volatile agent Substances 0.000 description 9
- 239000012267 brine Substances 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 8
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000003818 flash chromatography Methods 0.000 description 7
- 239000000543 intermediate Substances 0.000 description 7
- JICGTNNQQNZRHZ-UHFFFAOYSA-N oct-1-yn-1-ol Chemical compound CCCCCCC#CO JICGTNNQQNZRHZ-UHFFFAOYSA-N 0.000 description 7
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- 229960001866 silicon dioxide Drugs 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000003208 petroleum Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 5
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- RRKTZKIUPZVBMF-IBTVXLQLSA-N brucine Chemical compound O([C@@H]1[C@H]([C@H]2C3)[C@@H]4N(C(C1)=O)C=1C=C(C(=CC=11)OC)OC)CC=C2CN2[C@@H]3[C@]41CC2 RRKTZKIUPZVBMF-IBTVXLQLSA-N 0.000 description 5
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 5
- 238000011097 chromatography purification Methods 0.000 description 5
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 5
- 230000008034 disappearance Effects 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 5
- 150000004702 methyl esters Chemical class 0.000 description 5
- 238000010626 work up procedure Methods 0.000 description 5
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 4
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229960003395 carboprost Drugs 0.000 description 4
- DLJKPYFALUEJCK-MRVZPHNRSA-N carboprost Chemical compound CCCCC[C@](C)(O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C\CCCC(O)=O DLJKPYFALUEJCK-MRVZPHNRSA-N 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 229910001873 dinitrogen Inorganic materials 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000010907 mechanical stirring Methods 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 4
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- RRKTZKIUPZVBMF-UHFFFAOYSA-N brucine Natural products C1=2C=C(OC)C(OC)=CC=2N(C(C2)=O)C3C(C4C5)C2OCC=C4CN2C5C31CC2 RRKTZKIUPZVBMF-UHFFFAOYSA-N 0.000 description 3
- 230000005587 bubbling Effects 0.000 description 3
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000006196 deacetylation Effects 0.000 description 3
- 238000003381 deacetylation reaction Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
- 125000002346 iodo group Chemical group I* 0.000 description 3
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 3
- XNGIFLGASWRNHJ-UHFFFAOYSA-M phthalate(1-) Chemical compound OC(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-M 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- PGOLTJPQCISRTO-UHFFFAOYSA-N vinyllithium Chemical compound [Li]C=C PGOLTJPQCISRTO-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- QQCOAAFKJZXJFP-XAYIDPIISA-N 15-methyl-15R-PGF2alpha methyl ester Chemical compound CCCCC[C@](C)(O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)OC QQCOAAFKJZXJFP-XAYIDPIISA-N 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- DHNDDRBMUVFQIZ-UHFFFAOYSA-N 4-hydroxycyclopent-2-en-1-one Chemical class OC1CC(=O)C=C1 DHNDDRBMUVFQIZ-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 238000005828 desilylation reaction Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- VCJMYUPGQJHHFU-UHFFFAOYSA-N iron(3+);trinitrate Chemical compound [Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VCJMYUPGQJHHFU-UHFFFAOYSA-N 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- SNHOZPMHMQQMNI-UHFFFAOYSA-N lithium;2h-thiophen-2-ide Chemical compound [Li+].C=1C=[C-]SC=1 SNHOZPMHMQQMNI-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- QVXSANNZCZLRJJ-UHFFFAOYSA-N methyl 7-(3-hydroxy-5-oxocyclopenten-1-yl)hept-5-ynoate Chemical compound COC(=O)CCCC#CCC1=CC(O)CC1=O QVXSANNZCZLRJJ-UHFFFAOYSA-N 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- WJCXADMLESSGRI-UHFFFAOYSA-N phenyl selenohypochlorite Chemical compound Cl[Se]C1=CC=CC=C1 WJCXADMLESSGRI-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid group Chemical group C(C=1C(C(=O)O)=CC=CC1)(=O)O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- KXCAEQNNTZANTK-UHFFFAOYSA-N stannane Chemical class [SnH4] KXCAEQNNTZANTK-UHFFFAOYSA-N 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 2
- 238000005809 transesterification reaction Methods 0.000 description 2
- ZBDMJPAJZFSKPR-SECBINFHSA-N (3s)-3-methyloct-1-yn-3-ol Chemical compound CCCCC[C@](C)(O)C#C ZBDMJPAJZFSKPR-SECBINFHSA-N 0.000 description 1
- UNBRKDKAWYKMIV-QWQRMKEZSA-N (6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@H](CO)CC)C2)=C3C2=CNC3=C1 UNBRKDKAWYKMIV-QWQRMKEZSA-N 0.000 description 1
- ATHVAWFAEPLPPQ-VRDBWYNSSA-N 1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC ATHVAWFAEPLPPQ-VRDBWYNSSA-N 0.000 description 1
- GULNLSGTYCQLLM-UHFFFAOYSA-N 3-hydroxycyclopentan-1-one Chemical compound OC1CCC(=O)C1 GULNLSGTYCQLLM-UHFFFAOYSA-N 0.000 description 1
- ZBDMJPAJZFSKPR-UHFFFAOYSA-N 3-methyloct-1-yn-3-ol Chemical compound CCCCCC(C)(O)C#C ZBDMJPAJZFSKPR-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- DAPZSGCXUJECAI-UHFFFAOYSA-N 4-[tert-butyl(dimethyl)silyl]oxycyclopent-2-en-1-one Chemical compound CC(C)(C)[Si](C)(C)OC1CC(=O)C=C1 DAPZSGCXUJECAI-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 description 1
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 229910011777 Li2 S Inorganic materials 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 241001282153 Scopelogadus mizolepis Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000004133 Sodium thiosulphate Substances 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- XUTQYQHGALCMNU-UHFFFAOYSA-N [carboxy(propan-2-yl)amino]-propan-2-ylcarbamic acid Chemical compound CC(C)N(C(O)=O)N(C(C)C)C(O)=O XUTQYQHGALCMNU-UHFFFAOYSA-N 0.000 description 1
- 125000000746 allylic group Chemical group 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- STIAPHVBRDNOAJ-UHFFFAOYSA-N carbamimidoylazanium;carbonate Chemical compound NC(N)=N.NC(N)=N.OC(O)=O STIAPHVBRDNOAJ-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000004296 chiral HPLC Methods 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- XCIXKGXIYUWCLL-HOSYLAQJSA-N cyclopentanol Chemical class O[13CH]1CCCC1 XCIXKGXIYUWCLL-HOSYLAQJSA-N 0.000 description 1
- BGTOWKSIORTVQH-HOSYLAQJSA-N cyclopentanone Chemical group O=[13C]1CCCC1 BGTOWKSIORTVQH-HOSYLAQJSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- SMBQBQBNOXIFSF-UHFFFAOYSA-N dilithium Chemical compound [Li][Li] SMBQBQBNOXIFSF-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- CHDFNIZLAAFFPX-UHFFFAOYSA-N ethoxyethane;oxolane Chemical compound CCOCC.C1CCOC1 CHDFNIZLAAFFPX-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- UKJFVOWPUXSBOM-UHFFFAOYSA-N hexane;oxolane Chemical compound C1CCOC1.CCCCCC UKJFVOWPUXSBOM-UHFFFAOYSA-N 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical class [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000006263 metalation reaction Methods 0.000 description 1
- MJJQYDLZLSJJMW-UHFFFAOYSA-N methyl 7-hydroxyhept-5-ynoate Chemical compound COC(=O)CCCC#CCO MJJQYDLZLSJJMW-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960000328 methylergometrine Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- SFDZETWZUCDYMD-UHFFFAOYSA-N monosodium acetylide Chemical compound [Na+].[C-]#C SFDZETWZUCDYMD-UHFFFAOYSA-N 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001979 organolithium group Chemical group 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 1
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
- WGCXTGBZBFBQPP-UHFFFAOYSA-N prostaglandin E2 methyl ester Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(=O)OC WGCXTGBZBFBQPP-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- FGTJJHCZWOVVNH-UHFFFAOYSA-N tert-butyl-[tert-butyl(dimethyl)silyl]oxy-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)O[Si](C)(C)C(C)(C)C FGTJJHCZWOVVNH-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 1
- 125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 description 1
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to novel process for the preparation of prostaglandin compounds which are useful as medicaments.
Description
NOVEL PROCESS
The present invention relates to novel process for the preparation of prostaglandin compounds which are useful as medicaments.
s Prostaglandins (PGs) are a family of 20-carbon fatty acids found in virtually all mammalian cells and are biosynthesised from C-20 polyunsaturated fatty acids via cyclooxygenase enzyme system (S. Bergstroem., Science, 157, 382, 1967). For several decades, PGs have been the focus of extensive efforts in synthetic chemistry. Because of the potential ~o therapeutic advantages, increasing attention is being focused on PG
analogs. The non-availability of suitable natural source coupled with their potential drug utility has led to the clinical development of a number of synthetic PG analogs. Among them, particularly interesting, both pharmacologically and clinically, are analogs incorporating methyl groups into the prostaglandin skeleton at C-1.5 (a). E. Yankee et al., J. Amer. Chem.
Soc., 96, ~s 5865, 1974) b) E. Yankee et al., J. Amer. Chem. Soc., 94, 3651, 1972).
c). E. Yankee et al., J. Amer. Chem. Soc., 96, 5875, 1964) and references cited therein). The most rapid mode of metabolism (deactivation) of the natural PGs in man bas been shown to be the oxidation of the allylic C-15 alcohol, followed by very rapid reduction of the 13-14 double bond. The enzyme responsible for the oxidation, 15-hydroxy 2o prostaglandin dehydrogenase has been isolated from a variety of tissue preparations (B.
Samuellson et al., Advanc. Biosci., 9, 7, 1973).
Of particular interest is the 15-methyl PGF2a (carboprost, Upjohn). Carboprost is clinically listed for treatment of post partum haemorrage as an alternative to a methylergometrine or where the latter has produced inadequate response.
Intramuscular injection of 250 mg of carboprost in sterile aqueous solution is the best therapy now available, very successful in cases ready for uterectomy due to bleeding not stoppcd by methergin etc. This has been registered for this indication in Sweden and India (available under the brand names Prostinefem in Sweden and Prosodin in India).
The development of a total synthetic route for carboprost is highly desirable because of its promising clinical potential. A large number of strategies towards the synthesis of PGs have been reported (E.J. Corey et al., J. Amer. Chem. Soc., 9(1, 3245 and 3247, 1968).
However, known synthetic procedures often involve a multistep linear synthesis approach 3s leading to high cost and a low overall yield of the final product. Noyori et al reported a convergent three-component coupling process, wherein the entire carbon framework is assembled stereoselectively by tandem alkylation of an appropriate optically active enone (R. Noyori et al., Angew. Chem. Int. Edn.(Eng.)., 23, 847, 1984 and references cited therein). The prostaglandin PGEz has also been synthesised using solid phase chemistry (S
Chen, IBC International Conference on Combinatorial synthesis of natural products, December 1997).
The most recent approach which is frequently used for the syntheses of PGs involves the conjugate addition of an organometallics to an a-substituted 4-hydroxy 2-cyclopentenone (M.P.L. Caton in "New Synthetic Routes to Prostaglandins "., Academic Press N.Y., pg ~0 105, 1982 and F. Sato et al." J. Org Chem., 59, 6153, 1994). The two-component process consists of two independent but complementary routes: introduction of a o-side chain to an endo-enone bearing an a-side chain and introduction of a-chain to an exo-enone bearing an o-side chain.
~s The present invention involves the use of enantiomerically pure endo-enone (II) bearing an a-sidechain and the desired o-chain was introduced via conjugate addition of a higher order cuprate generated using an enantriomerically pure ~-chain iodide (VI). The delineated process describes the synthesis of endo-enone (II) in an excellent optical purity (> 99°lo ee), following the alkylation chemistry of the stabilised carbanion and its resolution using the zo technique of ultrasound mediated enzymatic irreversible transesterification. Herein, we have described a process for the preparation of enantiomerically pure (i-chain alcohol (>
99% ee) and its conversion to component B of very high optical purity. The reported procedures for the two component coupling process involve the conjugate addition of a higher order cuprate to the optically pure enone and are often encountered with an zs incomplete addition. This involves the recovery of the unreacted starting enone by exhaustive column chromatographic separation. In the present process we have demonstrated the use of Lewis acids such as BF3-etherate to activate the enone at temperature such as -78°C, followed by the conjugate addition of the higher order cuprate, resulting in the complete consumption of the enone. This procedure circumvents the so chromatographic purification of the coupled product and avoids the loss during chromatographic purification. Further post-coupling operations and the purification of the product in the last step affords carboprost methyl ester of USP
specifications.
In a first aspect the invention therefore provides a process for the preparation of a ss compound of formula (I):
WO 99!44990 PCT/SE99/00318 ,,~~ ~OMe O
HO ~~, / Me ~OH
in which R is CH=CH or CH2CH2, and R~ and R2 are both hydrogen or together form a bond, which comprises coupling a compound of formula (II];
s O
R (CH2~-C02Me PO
in which R is as defined in formula (I) and P is a protecting group, with a compound of io formula (III):
M / CSH~~
OP (~) is in which Pl is a protecting group and M is a cuprate to give a compound of formula (IA):
,.~~-R-(CHZ)3 C02Me PO'~', / , CsH~i OP' in which P and Pl are as defined above, and there after in any order:
~ optionally reducing the compound (IA) ~ . removing any protecting groups.
The present invention relates to novel process for the preparation of prostaglandin compounds which are useful as medicaments.
s Prostaglandins (PGs) are a family of 20-carbon fatty acids found in virtually all mammalian cells and are biosynthesised from C-20 polyunsaturated fatty acids via cyclooxygenase enzyme system (S. Bergstroem., Science, 157, 382, 1967). For several decades, PGs have been the focus of extensive efforts in synthetic chemistry. Because of the potential ~o therapeutic advantages, increasing attention is being focused on PG
analogs. The non-availability of suitable natural source coupled with their potential drug utility has led to the clinical development of a number of synthetic PG analogs. Among them, particularly interesting, both pharmacologically and clinically, are analogs incorporating methyl groups into the prostaglandin skeleton at C-1.5 (a). E. Yankee et al., J. Amer. Chem.
Soc., 96, ~s 5865, 1974) b) E. Yankee et al., J. Amer. Chem. Soc., 94, 3651, 1972).
c). E. Yankee et al., J. Amer. Chem. Soc., 96, 5875, 1964) and references cited therein). The most rapid mode of metabolism (deactivation) of the natural PGs in man bas been shown to be the oxidation of the allylic C-15 alcohol, followed by very rapid reduction of the 13-14 double bond. The enzyme responsible for the oxidation, 15-hydroxy 2o prostaglandin dehydrogenase has been isolated from a variety of tissue preparations (B.
Samuellson et al., Advanc. Biosci., 9, 7, 1973).
Of particular interest is the 15-methyl PGF2a (carboprost, Upjohn). Carboprost is clinically listed for treatment of post partum haemorrage as an alternative to a methylergometrine or where the latter has produced inadequate response.
Intramuscular injection of 250 mg of carboprost in sterile aqueous solution is the best therapy now available, very successful in cases ready for uterectomy due to bleeding not stoppcd by methergin etc. This has been registered for this indication in Sweden and India (available under the brand names Prostinefem in Sweden and Prosodin in India).
The development of a total synthetic route for carboprost is highly desirable because of its promising clinical potential. A large number of strategies towards the synthesis of PGs have been reported (E.J. Corey et al., J. Amer. Chem. Soc., 9(1, 3245 and 3247, 1968).
However, known synthetic procedures often involve a multistep linear synthesis approach 3s leading to high cost and a low overall yield of the final product. Noyori et al reported a convergent three-component coupling process, wherein the entire carbon framework is assembled stereoselectively by tandem alkylation of an appropriate optically active enone (R. Noyori et al., Angew. Chem. Int. Edn.(Eng.)., 23, 847, 1984 and references cited therein). The prostaglandin PGEz has also been synthesised using solid phase chemistry (S
Chen, IBC International Conference on Combinatorial synthesis of natural products, December 1997).
The most recent approach which is frequently used for the syntheses of PGs involves the conjugate addition of an organometallics to an a-substituted 4-hydroxy 2-cyclopentenone (M.P.L. Caton in "New Synthetic Routes to Prostaglandins "., Academic Press N.Y., pg ~0 105, 1982 and F. Sato et al." J. Org Chem., 59, 6153, 1994). The two-component process consists of two independent but complementary routes: introduction of a o-side chain to an endo-enone bearing an a-side chain and introduction of a-chain to an exo-enone bearing an o-side chain.
~s The present invention involves the use of enantiomerically pure endo-enone (II) bearing an a-sidechain and the desired o-chain was introduced via conjugate addition of a higher order cuprate generated using an enantriomerically pure ~-chain iodide (VI). The delineated process describes the synthesis of endo-enone (II) in an excellent optical purity (> 99°lo ee), following the alkylation chemistry of the stabilised carbanion and its resolution using the zo technique of ultrasound mediated enzymatic irreversible transesterification. Herein, we have described a process for the preparation of enantiomerically pure (i-chain alcohol (>
99% ee) and its conversion to component B of very high optical purity. The reported procedures for the two component coupling process involve the conjugate addition of a higher order cuprate to the optically pure enone and are often encountered with an zs incomplete addition. This involves the recovery of the unreacted starting enone by exhaustive column chromatographic separation. In the present process we have demonstrated the use of Lewis acids such as BF3-etherate to activate the enone at temperature such as -78°C, followed by the conjugate addition of the higher order cuprate, resulting in the complete consumption of the enone. This procedure circumvents the so chromatographic purification of the coupled product and avoids the loss during chromatographic purification. Further post-coupling operations and the purification of the product in the last step affords carboprost methyl ester of USP
specifications.
In a first aspect the invention therefore provides a process for the preparation of a ss compound of formula (I):
WO 99!44990 PCT/SE99/00318 ,,~~ ~OMe O
HO ~~, / Me ~OH
in which R is CH=CH or CH2CH2, and R~ and R2 are both hydrogen or together form a bond, which comprises coupling a compound of formula (II];
s O
R (CH2~-C02Me PO
in which R is as defined in formula (I) and P is a protecting group, with a compound of io formula (III):
M / CSH~~
OP (~) is in which Pl is a protecting group and M is a cuprate to give a compound of formula (IA):
,.~~-R-(CHZ)3 C02Me PO'~', / , CsH~i OP' in which P and Pl are as defined above, and there after in any order:
~ optionally reducing the compound (IA) ~ . removing any protecting groups.
Suitably R is CH=CH or CH2CH2, preferably R is CH=CH.
Suitably Rl and R2 are both hydrogen or together form a bond such that the groups ORS
and R2 form a carbonyl group. Preferably RI and R2 are both hydrogen.
The groups P and Pl, which can be the same or different, can be any suitable oxygen protecting groups, for example tetrahydropyran and, in particular, silyl protecting groups such as t-butyldiphenylsilyl, dimethylphenylsilyl, triethylsilyl, t-butyldimethylsilyl (TBDMS), trimethylsilyl (TMS) and triisopropylsilyl . Preferably P is TBDMS
and P~ is ~o TMS.
The reaction of compounds of formula (II) and (III) is carried out in a suitable solvent such as THF-hexane, THF-ether, preferably THF/ether. Preferably the reaction is carried out at reduced temperature, for example at about -78°C. Preferably the reaction is carried out in is the presence of a Lewis acid, particularly in the presence of BF3.OEt2. It has been found that the use of BF3.OEt2 not only activates the enone at low temperatures and drives the reaction to completion, but also circumvents the problem of dehydration at the position. The higher order cuprate of formula (III) is preferably generated using anorgano-lithium reagent, preferably butyl lithium.
Reduction of a compound of formula (IA) can be carried out using known reducing agents.
For example reduction of the cyclopentanone is preferably carried out using a selective reducing agent such as K-selectride to give the desired cyclopentanol isomer.
Reduction of the triple bond can be carried out using conventional techniques such as Lindlar 2s hydrogenation.
Removal of protecting groups can be carried out using conventional procedures.
For example when protecting groups P and Pt are both silyl groups deprotection of both groups can be achieved using a fluoride reagent such as TBAF in a suitable solvent such as 'TIC.
3o Preferably the cyclopentanone moiety is reduced, followed by deprotection of the groups P
and Pl followed by reduction of the triple bond to furnish the desired compounds of formula (1).
Compounds of formula (II) can be prepared from compounds of formula (IV):
O
L
PO (N) in which P is as defined in formula (II) and L is a leaving group with a compound of formula (V}:
Hal-CH2 (CH2)3 C02Me (V) in which Hal is halogen in the presence of an organolithium reagent.
Preferably L is a group such as a -SaPh to stabilise the carbanion generated and Hal is bromo or iodo, io preferably iodo.
Compounds of formula (IV} in which L is SePh can be prepared from the corresponding enone and phenylselenyl chloride using literature procedures. The enone can be prepared by protecting the corresponding alcohol, for example by treating with TBDMS
chloride is conventional conditions.
Compounds of formula (V) can be prepared by halogenation of the con~esponding alcohol which in turn is prepared using known procedures as exemplified herein.
zo The compound of formula (~ is a suitable cuprate, in particular a higher order cuprate and preferably a thienyl cuprate, in particular dilithium [3-methyl, 3-(trimethylsilyl~xy octyl}-2-thienyl cyanocuprate of formula (BIA):.
~N
Cu ~ CsH» Li2 S
OP
2s which is prepared from the corresponding halide of formula (Vn:
Hal / CSH»
.:
OP' in which Hal is halogen, in particular iodo, and PI is a protecting group as defined in formula (III), preferably aTMS group. This compound can be prepared according to the procedures exemplified herein.
Novel intermediates form a further aspect of the invention.
The invention is illustrated by the following Examples.
Intermediate 1 a) Methyl-7-hydroxy hept-5-ynoate.
s The title compound was prepared according to the method of R.J.K. Taylor et al., Tetrahedron, 42, 5849-56 (1986) as an oil, by 130 - 132°C at O.Smm Hg.
1H NMR (CDCI3): 8 4.I5 (m, 2H), 3.6 (s, 3H), 3.0 (bs, IH, exchanges with D20), 2.35 (t, 2H), 2.25 (t, 2H) and I.75 (q, 2H).
~o b) Methyl-7-iodo hepta-5-yonate:
The title compound was prepared from the above a-alcohol according to the method of Carl Johnson et al., JACS,110, 4726-35 (1988) as an oil, by 110 - 113°C
at 0.9 mm Hg.
~s 1H NMR (CDCI3~: b 3.6 - 3.7 (bs,SH), 2.4 (t, 2H), 2.25 (t, 2H), 1.75 (q, 2H).
Intermediate 2.
SYNTHESLS OF RAGEMIC 4-HYDROXY CYCLOPENTENONE.
The title compound was prepared according to the method of M. Minai, Jap.
Patent., Kokai No. 62236,1982.
1H NMR (CDCI3); 8 7.55 (dd, J = 6Hz, I.SHz, 1H), 6.2 (d, J = 6 Hz, 1H), 5.05 (m, IH), 2s 2.75 (dd, J = 17 Hz, 6 Hz, 1H), 2.25 (dd, J = 17 Hz, 6 Hz, 1H) and 2.0 (bs, 1H, exchanges with D20).
Intermediate 3 Synthesis of 1-lodo(S)-methyl-3-(trimethylsilyloxy)-oct-2-ene.
a) Racemic 3-methyl-octa-1-yn-3-of A 3-necked 3litre r.b. flask was cooled under a stream of nitrogen gas and was fitted with mechanical stirrer through the centre neck. Side arm was connected to a socket with gas 3s inlet and a cold, finger condenser. Another side arm was connected to a nitrogen inlet under static pressure. The cold finger condenser was charged with dry ice-acetone mixture (-78°C) and the reaction flask was kept in an insulated bath. Anhydrous ammonia gas (dried through a wash bottle containing KOH pellets) was bubbled at a steady rate through the gas inlet in an atmosphere of nitrogen, whereupon ammonia condenses into the reaction flask. It took around 2 hr. to condense ammonia gas to obtain around 1.6 Litre of liquid s ammonia. At this stage the condensation of ammonia was stopped and in the place of ammonia bubbler was connected the nitrogen inlet. The other side arm was stoppered.
Sodium metal was cut into small pieces and washed with anhydrous hexane. After the addition of the first piece while stirring mechanically, the colour of the reaction mixture turned blue as the metal dissolved. As soon as the blue colour persists, ferric nitrate was io added through the side arm, whereupon the reaction becomes exothermic and upon stirring the blue colour discharges to afford the greyish white sodium amide. The addition of sodium metal was continued. Upon addition of sodium metal, the appearance of blue colour was observed and as the stirring is continued, the greyish white coloration is observed. After the complete addition of the metal (it took 1 hr. for the completion of is addition of sodium metal), the reaction mixture was stirred for about 0.5 hr to ensure the complete formation of sodium amide. During the whole process a static pressure of nitrogen gas and the temp. of -78°C in the cold finger condenser was maintained. Through one side arm, a gas inlet tube was inserted and bubbling of acetylene gas was continued at a steady rate (acetylene was bubbled through a paraffin trap and an empty trap kept at -78'C) 20 over a period of 5 hr. to ensure the complete formation of sodium acetylide. Acetylene bubbling was stopped and a pressure equalising dropping funnel was fitted to one side arm of the reaction flask and was charged with 2-heptanone (287g, 2.511 mol) in anhydrous ether (75 ml). The contents were then added dropwise while stirring over a period of 1 hr.
(exothermic reaction!). The dropping funnel was rinsed with ether {40 ml) and the is washings were added to the reaction flask. The contents in the reaction flask were stirred vigorously and the bubbling of acetylene gas was continued for another 3 hr.
and allowed to stand overnight without stirring. The temp. in the cold finger condenser was raised to ambient temp. slowly the facile evaporation of ammonia gas.
3o Workup: The mechanical stirrer and the cold finger condenser was dismantled and the 3-necked flask was cooled to 0°C under nitrogen using an ice-bath and to this was added NH4CI solution in water in small lots of 50 ml each. The reaction mixture was stirred at 0°C for a further 0.5 hr. and warmed to RT and stirred at RT for 2 hr.
The resultant solution was filtered over a celite bed using a G-3 sintered funnel. The residue was washed ss with pet ether (2 x 150 ml). The contents were transferred to a separatory funnel and the aqueous layer was separated. Aqueous layer was extracted with pet ether (3 x 500 ml).
Combined PE portion was washed with water (2 x 500 ml), brine ( 100 ml) and dried over anhydrous Na2SO4. Removal of volatiles in vacuo afforded 352 gm of crude ~i-chain alcohol. This was further purified by distillation in vacuum (bp 76-78°C at 17mm of Hg) to get 330 gm of (3-chain alcohol (2.360 Mols, 94% yield). Initial forerun in the distillation s furnished unreacted 2-heptanone (bp. 67-69°C at l7mm of Hg). This was recycled with next batch for the preparation of racemic octynol.
Yield of racemic (3-chain alcohol: 330 gm, 2.360 mols, 94%. Purity of > 99%
was ascertained by GC analysis: column: OV-101, 90pC, RT for octynol: 5 min: for heptanone:
io 2.5 min.).
b). 3-Methyl-3-carboxy-oct-1-yn-3-of hydrogen phthalate.
i). Recrystallisation of phthalic anhydride - representation procedure.
is A precooled 5 litre r.b. flask with a magnetic stirring bar was charged with 570 gm of phthalic anhydride and 2.3 litre of chloroform. The contents were refluxed on a water bath for 0.5 hr and filtered hot on a sintered funnel. Undissolved residue is phthalic acid. The filterate was left in the refrigerator in a tightly stoppered flask to get the crystalline phthalic 2o anhydride. This was filtered, washed with hexane and dried in a desiccator.
mp 130-131°C.
ii) 3-Methyl-3-carboxy-oct-1-yn-3-of hydrogen phthalate.
is A pre-cooled 5 litre r.b. flask with a magnetic stirring bar was charged with the racemic octynol (0.92kg, 6.57 mol), phthalic anhydride (0,979kg, 6.606 mol), DMAP
(O.O8kg, 0.658mo1) and triethylamine (0.67kg, 6.617mo1). The reaction mixture was refluxed at 80°C for 6 hr and allowed to cool to RT and stirred overnight. The progress of the reaction was monitored by TLC (solvent system: 20% EtOAc in PE) for the disappearance of the so starting octynol. The reaction mixture was left overnight at RT.
Worlcup: A 20 Litre r.b. flask with a flange and a mechanical stirring assembly was charged with 7.4 Litre of water and 0.731 litre of cone. HCI and cooled to OpC
using an ice bath. To this mixture was added the hemiphthalate reaction mixture while stirring, 3s followed by the addition of chloroform (2.3 litre). The stirring was continued for 1 hr. The organic layer was separated and the aqueous layer was extracted with chloroform (3 x 3 litre). Combined organic layer was washed with water (2 x 500 ml) and brine (500 ml).
This was dried over anhydrous Na2S04 and volatiles were removed using a rotary evaporator and dried in high vacuum.
s In another 20 Litre r.b. flask with a flange and a mechanical stirring assembly was taken petr. ether S.5 Litre) and cooled to 0°C. Hemiphthalate from the earlier step was poured into PE while stirring and stirred for 1 hr., whereupon the desired hemipthalate ester crystallises. This was filtered using a buchner funnel, residue washed with cold PE (500 ml) and dried in suction. This residue was air dried (m p 61-62°C, 0.915 Kg,). The mother io liquor from filitration was concentrated in vacuo using a rotary evaporator and kept in the refrigerator to get an additional lot of hemiphthalate ester (2"d crop, 0.43 Kg, m p 61-62°C). However, by repeating the sequence for the third crop, the compound obtained (0.1 S 1 Kg) showed higher m p and hence was kept aside and taken up for the recovery of racemic octynol.
a Yield of hemiphthalate ester: 1.348 Kg, 71 %.
c). Brucine phthalate of 3-Methyl-oct-1-yn-3-ol.
A pre-cooled 20 litre flanged r.b. flask with a mechanical stirnng assembly was charged with the hemiphthalate ester of racemic octanol (0.94kg, 3.262 mol), brucine ( 1.432kg, 3.327 mol) and anhydrous acetone (3.751). The reaction mixture was heated at SOPC for 1 2o hr and allowed to cool to RT and stirred overnight at RT.
Wockup: The precipitated solid was filtered using a buchner funnel and washed with cold acetone (2 x 250 ml) to get rid of the contamination of undesired diastereomer. The resulting solid was air dried.
Yield: 0.739 Kg, 1.028 mols, 31.5°!0. m p 158-159°C, [a]D = -12.0° t 0.5(c 0.88, EtOH).
zs The mother liquor was kept aside for the recovery of brucine.
d). Hemiphthalate ester of (S)-octynol from brucine salt: (S)- 3-Methyl-3-carboxy-oct-1-yn-3-of hydrogen phthalate.
3o A pre-cooled 20 litre flanged r.b. flask with a mechanical stirring assembly was charged with brucine salt (0.827kg, 1.15 mol) and ether (8.21). To this was added conc. HCI (0.83 1) in small lots at 0°C while stirring. The reaction mixture was stirred at 0°C for 2 hr and allowed to warm to RT.
Workup: The contents were transferred to a separatory funnel and the ether layer was separated. Aqueous layer was extracted with ether (2 x 500 ml). Combined ether layer was washed with water (2 x 250 ml), brine (250 ml) and dried over anhydrous Na2S04.
s Removal of volatiles in vacuo afforded the desired hemipthalate ester of (S)-octynol as a viscous material. The aqueous layer was discarded.
Yield of hemiphthalate ester of (S)-octynol: 0.332 Kg (near quantitative).
This was used as such without purification for further reaction.
~o e). (S)-3-Methyl-oct-1-yn-3-ol.
A pre-cooled 20 litre flanged r.b. flask with a mechanical stirring assembly and a reflux condenser was charged with the hemiphthalate ester of (S)-octynol (0.332 kg, 1.151 mol) and to this was added NaOH solution (0.504 kg in 3.61 water} at RT. The reaction mixture ~s was refluxed on a water bath for 2 hr. The reaction mixture was cooled to RT, whereupon the octynol layer separates. The contents were transferred to a separatory funnel and the supernatent layer was separated. The aqueous layer was extracted with petroleum ether (3 x 500 ml) and mixed with the octynol fraction. Combined organic portion was washed with distilled water (3 x 500 ml) till the pH is 7. The organic portion was dried over 2o anhydrous Na2S04 and removal of volatiles furnished 155 gm (96%) of crude (S)-octynol which was further purified by distillation in vacuo. b p. 73-76°C at 14-15 mm of Hg.
Yield: 128.87 gm, 0.921 mols, 80%, [a]D = -2.3° t 0.5(c 2.7, EtOH).
Reported [a]D =
2.33° (c 2..625, EtOH).
f7. (S)-3-Methyl-3-(trimethylsilyl~xy-oct-I-yne.
a A pre-cooled 1 litre r.b. flask with a magnetic stirring bar was charged with (S}-octynol (29g, 0.207 mol) and DMF. The reaction mixture was cooled to 0°C (ice-bath) under nitrogen atmosphere. To the reaction mixture was added imidazole (39.44g, 0.58 mol) in small portions (of - 5 gm) at 0°C and stirred to 15 min. To the reaction mixture was 3o added TMS chloride ( 33.72g, 0.310 mol) dropwise by means of a syringe over a period of 45 minutes and then stirred at 0°C for 1 hr. The reaction mixture was allowed to warm to RT and stirred at RT overnight. The progress of the reaction was monitored by TLC
(solvent system: 10% EtOAc in petroleum ether) for the disappearance of the starting alcohol.
Workup: The reaction mixture was poured into ice water (750 ml) and extracted with ether. The supernatent ether layer was separated and the aqueous layer was extracted with ether (3 x 250 ml). Combined organic portion was washed with water (2 x 100m1) and brine (50 ml). This was dried over anhydrous Na2S04 and volatiles were removed using a s rotary evaporator and dried in high vacuum. This was purified by distillation under reduced pressure to get the title product:
bp. 87-90°C at 12-15 mm of Hg.
Yield: 35.09 gm, 165.5 mmols, 80%.
~o g). (S)-3-Methyl-3-(trimethylsilyl)oxy-1-(n-tributylstannyl)-oct-1-ene (E).
A pre-cooled 500 ml r.b. flask with a magnetic stirring bar was charged with TMS ether of (S)-octynol 7.SOg, 35.37 mmol), TBTH ( 16.31 g, 35.4 mmol) and AIBN (0.4g, 2.47 mmol).
The reaction mixture was evacuated and flushed with nitrogen gas. The flask was then immersed in a preheated oil-bath at 130°C, whereupon a vigorous initiation reaction took is place with the evolution of hydrogen gas. (a suitable vent is desirable).
The reaction mixture was heated in an oil bath at 150°C for 3 hr and cooled to RT
under nitrogen atmosphere. To the reaction mixture was added petr. ether (150 ml) and allowed to stir at RT for 15 min. The reaction mixture was filtered over a celite bed using a G-3 sintered funnel. The residue was washed with anhydrous PE (60 ml) and the combined PE
layer, zo upon removal of volatiles afforded desired stannane derivative in quantitative yield.
Note: This derivative was stored in a tightly stoppered flask covered with an aluminium foil, under nitrogen. This is highly moisture and light sensitive! Large scale preparation would involve mixing of reactants followed by the addition of AIBN, once the operation temperature is attained.
zs h) 1-Iodo (S)-3-methyl-3-(trimethylsilyoxy)-oct-2-ene.
A pre-cooled 500 ml r.b. flask with a magnetic stirring bar was charged with stannane derivative (61.06g, 0.121 mol) and to this was added freshly distilled THF ( 170 ml). The reaction mixture was cooled to -78°C using dry ice-acetone bath and to this was added a 3o solution of N-iodo succinimide (27.31 g, 0.121 mol) in THF ( 100 ml) by means of a cannula at -78°C under nitrogen over a period of 45 min. The reaction mixture was stirred at -78°C for 1 hr. The temp. of the bath was gradually raised to RT and stirred at RT for 15 min. The progress of the reaction was monitored by TLC (solvent system: Petr.
ether) for the disappearance of starting material.
WO 99/44990 PC"T/SE99/00318 Workup: The reaction mixture was poured over ice and filtered over celite bed using a G-3 sintered funnel. The filitreate was extracted with PE (4 x I00 mI). Combined PE layer was washed with water ( 100 ml), 10% sodium thiosulphate solution ( 150 ml) and finally s with water (SO mI): PE portion was dried over anhydrous Na2S04 and removal of volatiles in vacuo afforded desired iodide (0.072 Kg). This was purified by high vacuum distillation (bp.79-82°C at 0.1 mm of Hg, 0.040 Kg, 0.118 Mols, 97%.
[a]D = -24.0° ~ 0.5(c, 1.61: CHCI3): reported [a]D = -22.5° (c, 1.2: CHCI3).
~ o Intermediate 4 Preparation of 4-[(tert-butyldimethylsilyl)oxy]-2-cyclopenten-1-one.
Prepared according to the method of R. Noyori., et al., Tetr. Lett., 28, 4719-20 (1987) from 4-hydroxycyclopentanone (intermediate 2, 10.1 g, 0.103 mmol}, 4-DMAP ( 1.21 g, is 0.00993 mol) and triethylamine (11.46g, 0.113 mmol).
Yield: 24.03 gm (pale brownish in colour). The material had some colouring impurities which were removed via distillation under reduced pressure. (bp. 82-86°C at lmm of Hg).
Yield of the desired product: 20.02 gm, 0.158 mots, 91.7%.
2o iH NMR (CDCI3); 8 7.4 (m, d, 1H), 6.1 (d, 1H), 4.9 {m, 1H) 2.6 (dd, 1H), 2.15 (d, 1H), 0.8 (s, 9H), 0.1 (s, 6H). The purity of the material was established by HPLC
using a chiracel-OD column using 1.5% isopropan-2-Ol in n-hexane.
Intermediate 5 as a) Preparation-of racemic 4-[(t-butyldimethylsilyl)oxy)-2-(phenylseleno)-2-cyclopenten-1-one Prepared according to the method of T. Toru, et al., J.Org. Chem., 57, 4719-20 (1992) from TBS-derivative 4-[(tert-butyldimethylsilyl~xy]-2-cyclopenten-1-one.
30 (23.84g, 0. I 12 mol), phenyl selenyl chloride (32.32g, 0.169 mol) and pyridine ( 14.69g, 0.186 mol).
Yield 37.14g, 90%.
1H NMR (CDCI3): 8 7.3-7.7 (m, SH), 4.85 {m, 1H}, 2.8-2.9 (dd, 1H) 2.35 (d, 1H), 0.8 (s, ss 9H) and 0 (s, 6H).
b). Preparation of Methyl 7-(3-Hydroxy-5-oxo-1-cyclopentene-1-yl)-5-heptynoate via a two-component coupling process.
s Prepared according to the method of T. Toru, et al., J.Org. Chem., 57, 3145-3152 (1992) from selenyl derivative 4-[(tert-butyldimethylsilyl~xy]-2-(phenylseleno)-2-cyclopenten-1-one.
(16.658, 45.3 mmol), bis(tributylstannane (28.948, 49.91 mmol), n-BuLi (35.6 ml of 1.4M
in hexane, 49.91 mmol), iodine (25.358, 95.28 mmol) and HMPA (26m1) in THF.
~o The product was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether. Yield of the pure product: 11.11 gm, 31.76 mmols, 70°k.
1H NMR (CDCI3); b 7.3 (s, 1H), 4.9 (m, 1H), 3.65 (s, 3H), 3.0 (bm, 3H), 2.75 (dd, 1H) is 2.45 (t, 2H), 2.25 (bt, 2H), 1.8 (q, 2H), 0.8 (s, 9H) and 0.1 (s.6H).
c). Methyl 7-(3-Hydroxy-5-oxo-1-cyclopentene-1-yl)-5-heptynoate Prepared according to the method of E.J. Corey et al, JACS., 94, 6190-91 (1972) from the zo TBS derivative (6.028, 17.22 mmol) , Methyl-7-[-3-tert butyldimethylsilyl~xy]-5-oxo-1-cyclopenten-1-yl]-kept-S-ynoate in a solution of AcOH: THF: water (3:1:1).
Yield 2.44 gm, 10.33 mmols, 60%. TLC: solvent system: 70% EtOAc in petroleum ether.
1H NMR (CDCI3); $ 7.4 (bs, 1H), 5.0 (bs, 1H), 3.65 (s, 3H), 3.0 (bm, 3H), 2.85 (dd, 1H) zs 2.45 (m, 2H), 2.25 (m, 2H), and 1.8 (q, 2H).
d) ENZYMATIC IRREVERSIBLE TRANSESTERIFICATION USING Lipase IN
VINYL ACETATE IN A SONICATOR BATH:
Prepared according to the methods of K.A. Babiak, et al., J. Org.Chem., 55, 3377-81, so (1990) and G Lin, et al., Tetr.Lett., 36, 6067-68 (1995) from the hydroxy-enone (4.78, 19.91 mmol, Methyl-7-[(3-hydroxy)-S-oxo-1-cyclopentene-1-yl]-hept-5-ynote and PPLipase and/or HPLipase (crude, 7.Sg) in vinyl acetate with sonication.
Yield of desired acetate 2.408, 43%.
1H NMR (CDCI3); 8 7.4 (bs, 1H), 5.75 (m, 1H), 3.65 (s, 3H), 3.05 (bm, 3H), 2.85 (dd, 1H), 2.4 (t, 2H), 2.25 (m, 2H), 2.1 (s, 1H) and 1.8 (q, 2H).
e} DEACETYLATION USING GUANIDINE IN METHANOL
s Preparation of a stock solution of Guanidine in Methanol:
Prepared according to the method of K.A. Babiak, et al., J. Org.Chem., 55, 3377-81, (1990) from guanidine carbonate (28.48, 0.158 mol), sodium metal (3.56g, 0.155 mol) in methanol (0.3081).
io Methyl-7-(((R)-3-hydroxy)-5-oxo-1-cyclopentene-1-yl]-kept-5-ynote.
Prepared according to the method of : K.A. Babiak, er al., J. Org.Chem., 55, 3377-81, (1990) from the (R) acetate ( 1.905g, 6.85 mmol) and guanidine in methanol.
is Note: it is recommended to carry out the deacetylation on a small scale before performing deacetylation on a rather big scale because of the sensitive nature of (3-hydroxy ketone.
Yield: 1.130 gm, 4.788 mmols, 70% yield, (90 optically pure). This was used for further 2o upgradation of optical purity using PPLipase and/or HPLipase as described below.
Procedure: Same as the earlier enzymatic resolution using a sonicator bath.
Enrichment was complete in 5 days. Desired product was isolated by flash chromatography in 40-50%
EtOAc in PE eluate. Yield of (R)-Acetate: optical purity: > 99.9%. This was further 2s deacetylated using guanidine in methanol to get 1.553 gm of optically pure alcohol (5.586 mmols, > 99.9% optically pure by chiral HPLC analysis.
f) MITSUNOBU INVERSION TO CONVERT UNDESIRED ENANTIOMER TO
THE DESIRED ENATIOMER:
Prepared according to the methods of K.A. Babiak, et al., J. Org.Chem., 55, 3377-81, (1990).
A precooled 250 ml. flask with a septum inlet and a magnetic stirring bar was charged with (S)-alcohol (2.S8g, 10.93 mmol of 88% optical purity), Ph3P {5.74g, 21.86 mmol) and 3s freshly distilled THF. The reaction mixture was cooled to 10°C and to this was added formic acid by means of a syringe, followed by the addition of diisopropylazodicarboxylate (DIAD, 4.42g, 21.86 mmol) and slowly warmed to RT. The pale yellow reaction mixture was stirred at RT for 12 hr. in an atmosphere of nitrogen gas. The progress of the reaction was monitored by TLC (solvent system: 70% EtOAc in PE).
s Worlcup: The solvent was removed in vacuo under pressure using a rotary evaporatorand the resulting brownish residue was dissolved in ether (70 ml) and triturated with n-hexane ( 16S ml) to precipitate phosphorous salts. The mixture was stirred at RT for 30 min. and filtered over a G-3 sintered funnel, washed with ether (2 x SO ml). Combined organic portion was transferred to another r.b. flask and volatiles were removed in vacuo using a io rotavapor. The resulting residue was dissolved in MeOH (120 ml) and to this was added alumina (activated, neutral, 100 gm) and stirred at RT overnight. The progress of the reaction was monitored by TLC (solvent system: 70% EtOAc in PE). The reaction mixture was filtered on a G-3 sintered funnel and the residual alumina was repeatedly washed with MeOH (3 x 10(? ml), combined filterate was subjected to flash evaporation is using a rotary evaporator to give 13.805 gm of the crude product. This was further purified by flash chromatography over a column of silicagel (400 gm, 200-400 mesh).
Initial elution with a gradient of 1S-60% EtOAc in petroleum ether gave undesired 1,2-diisopropyl dicarboxyhydrazine and the desired alcohol was obtained in 80-9S%
EtOAc in PE. The HPLC analysis using Chiracel-OD column indicated clean inversion at the chiral 2o centre (no noticeable racemisation) with an optical purity of 88% of the (R) isomer.
This product was further subjected to enzymatic transesterfication using HPL
in a sonicator to furnish desired (R)-acetate of >99% optical purity. Yield: 1.891 gm, 6.802 mmols, 70%. This was further deacetylated using guanidine in methanol, to get the desired as (R)-alcohol in > 99% optical purity. Yield: 1.166 gm, 4.94 mmols, 73%
yield.
g). Methyl-7-[(R)-3-tert-butyldimethylsilyl)oxy]-5-oxo-1-cyclopenten-1-yl]-hept-5-ynoate.
3o To a precooled 2S0 ml r.b. flask with a septum inlet and a magnetic stirring bar was taken TBDMS chloride ( 1.90g, 12.64 mmol) and dichloromethane. The solution was cooled to 0°C using an ice-bath and to this was added imidazole ( 1.60g, 23.66 mmol) in one portion, followed by the addition of DMF. The reaction mixture was stirred at 0°C for 1 S min. In another pre-cooled flask was taken (R)-enone alcohol ( 1.99g, 8.4 mmol) in anhydrous 3s CH2CIz (3 ml) and this was transferred to the reaction flask under nitrogen by means of a cannula. The washings ( 1 mI) were transferred to the reaction flask and stirred at 0°C for 2 WO 99/44990 PC'T/SE99/00318 hr. The reaction mixture was allowed to warm to RT and stirred further overnight (- 10 hr.). The progress of the reaction was monitored by TLC (solvent system:
petroleum.ether:EtOAc, 3:7).
s Workup: The reaction mixture was poured over ice-water and extracted with dichloromethane (3 x 100 ml). Combined organic layer was washed with water (30 ml) and with brine. Organic portion was dried over anhydrous Na2S04, removal of voladles in vacuo furnished 3.80 gm of oily material, which was further purified by flash chromatography on a column of silica gel ( 150 gm, 200-400 mesh) in 15-25%
EtOAc in to pet. ether eluate. Yield of the desired product: 2.90 gm, 4.66 mmols, 70%.
TLC: solvent system: 70% EtOAc in petr. ether.
1H NMR (CDCI3); 8 7.4 (bs, 1H), 5.0 (bs, 1H), 3.65 (s, 3H), 3.0 (bm, 3H), 2.85 (dd, 1H), 2.45 (m, 2H), 2.25 (m, 2H) and 1.8 (q, 2H). The purity of the material was established by is HPLC using a chiracel-OD column using 7% isopropan-2-of in n-hexane.
Example 1.
a). 2-ThienylUt6ium Procedure: In a pre-cooled 100 ml r.b. flask with a septum inlet and a magnet stirring bar was taken freshly distilled THF (30 ml) and thiophene ( 1.59 ml, 20 mmols).
The reaction mixture was cooled to -60°C (dry ice-CHCI3 bath) and to this was added n-BuLi ( 16.7 ml, 1.2M in hexane) dropwise by means of a syringe over a period of 15 min. The reaction zs mixture was stirred at -60°C for 1 hr. to ensure the completion of metallation. The colour of thienyllithium in THF was pale yellow.
b) Preparation of vinyllithium:
so Procedure: A pre-cooled 100 ml r.b. flask with a septum inlet and a magnetic stirring bar was charged with B-chain iodide TMS ether (6.8g, 20 mmol) in 30 ml of THF
(freshly distilled, anhydrous) and the contents cooled to -78°C {dry ice-acetone bath) under nitrogen. To this was added n-BuLi (21 mmol, 17.5 ml) dropwise by means of a syringe at -78°C over a period of 30 min. The reaction mixture became turbid with pale yellow ss precipitate of vinyllithium indicating the completion of reaction. The contents were further stirred at -78°C or 1 hr.
c) TWO-COMPONENT COUPLING PROCESS:
Procedure: To a precooled 500 ml r.b. flask with a septum inlet was added Cu(I)CN (20 s mmol, 1.79gm) and a magnetic stirring bar. The flask was capped with a rubber septum and heated with a heat gun under high vacuum to remove any traces of moisture, allowed to cool and purged with nitrogen. THF (30 ml) was added and the suspension cooled to -22°C (dry ice-CCI4 bath) under nitrogen. To this was added the solution of preformed 2-thienyllithium (step a) dropwise by means of a cannula over a period of 10 min. The ~o contents were washed with THF (5 ml) and added to the flask, whereupon the solution became homogenous (pale yellow colour) to afford the desired lower order cuprate. The reaction mixture was further stirred at -22°C for 1 hr.
To the above solution of the lower order cuprate was added the solution of vinyl lithium ~s (step b) dropwise by means of a cannula over a period of 10 min at -22°C, washed with THF (5 ml) and the solution stirred at -22°C for a further 1 hr. to provide a homogenous higher order cuprate (clear solution, pale yellowish orange colour). The resulting cuprate solution was cooled to -78°C (dry ice-acetone bath).
2o In a precooled 100 ml pear shaped flask was taken (R)-enone TBDMS ether (>
99%
optically pure, 3.5 gm, 10 mmols) and to this was added anhydrous ether (40 ml) by means of a syringe. The contents were cooled to -78°C using a dry ice-acetone bath for 10 min.
To this was added BF3:OEt2 ( 1.29 ml, 10.5 mmols) dropwise while stirring, by means of a syringe at -78°C and left at this temp. for 5 min. This solution was then added dropwise 2s (very slow dropwise addition!) to the solution of the higher order cuprate (obtained in step-c) at -78°C under nitrogen by means of a cannula over a period of 45 min. The flask of enone was washed with ether (Sml) and the washings transferred to the reaction flask over a period of 45 min. The stirring was continued at -78°C for 1.5 hr (progress of the reaction monitored by TLC, solvent system: pet. ether -10% EtOAc, for the disappearance of the 3o starting enone). The reaction mixture was quenched with saturated aqueous ammonium chloride solution (20 ml) at -78°C and warmed to RT. The reaction mixture was poured into a mixture of 150 ml distilled water and 300 ml of ether. The aqueous layer was extracted with ether (3 x 100 ml) and the combined organic portion was washed with brine, dried over anhydrous Na2S04. Removal of volatilities in vacuo afforded an oil ( 11.35 ss gm). This product was used as such for the further sequence without chromatographic purification. TLC: solvent system: pet ether-10% EtOAc: A part of the sample was purified by flash chromatography (silicagel, 1:20 ratio, 200-400 mesh) and the desired product was obtained in 20% EtOAc in PE eluate for characterisation, Rg 0.31, solvent system: pet.ether-10% EtOAc:
IH NMR (CDCI3): b 0.05 (s, 6H); 0.8-0.9 (m, 12H); 1.1-1.6 (m, lOH); 1.7-1.8 (m, 3H);
s 2.0-2.3 (m, 6H); 2.4 (t, 2H, J = 7.4 Hz); 2.6-2.9 (m, 3H); 3.65 (s, 3H); 4.1 (m, 1H); 5.3-5.5 (m,2H).
Example 2.
(5,6-Didehydro-11-O-(tert-butyldimethylsilyl)-15-O-(trimethylsilyl-13-(S)-methyl -i o PGF~ methyl ester Procedure: To a flame dried 250 ml r.b. flask with a septum inlet and a magnetic stirring bar, was added the crude TCC product [5,6-Didehydro-11-O-tent butyldimethylsilyl)-15-O-(trimethylsilyl)-13-(5~-methyl - PGE2 methyl ester]. (11.35 gm, from 10 mmol of the ~s enone) in THF (anhydrous, 35 ml). The solution was cooled to -78°C
and treated with a solution of K-selectride (32.85 ml, 30 mmol, 0.9M solution in THE dropwise by means of a syringe. The reaction mixture was allowed to stir at -78°C for 1.5 hr. and to this was added dropwise a 30% aqueous solution of H202 (4.54 ml, 40 mmol). Stirring was continued for another I S min, the cooling bath was removed and the reaction mixture Zo warmed to room temperature. Water (20 ml) was added and the organic phase separated.
The aqueous phase was extracted with EtOAc (3 x 50 ml). The combined organic layer was washed with brine (2 x 20 ml) and dried over anhydrous Na2S04. Removal of solvent in vacue furnished 13.516 gm of the desired crude product. This was used as such for further desilylation. TLC solvent system: 20% EtOAc in PE, Rf 0.2.
is A small portion of the selectride reduction product obtained in the earlier step was purified by flash chromatography using silicagel (60 gm, 200-400 mesh). The desired product was obtained in pet ether-30% EtOAc eluate: Rg 0.2 (solvent system pet.ether-20%
EtOAc). 1H
NMR (CDCI3): S 0.05 (s,6H); 0.8-0.9 (m, 12H); 1.2-1.6 (m, lOH); 1.7-1.9 (m, 3H); 2.I-2.3 30 (m, lOH); 2.4 (t, 2H J = 7.4 Hz); 3.65 (s, 3H); 3.9-4.0 (bs, 1H); 4.2-4.3 (bs, 1H); 5.3-5.5 (m, 2H).
Procedure: To a precooled 250 ml r.b. flask with a septum inlet and a magnetic stirring bar was added the crude selectride reduced product ( 13.52 gm) and THF
(anhydrous, 35 ss ml). The solution was cooled to 0°C and to this was added a solution of tetra-n-butyl ammonium flouride (30 mmols, 30 ml of 1M soln. In THF, 3 equiv.) dropwise by means of a syringe over a period of 5 min. Stirring was continued for 0.5 hr. at OPC
and 5 hr. at room temperature until the completion of reaction by TLC analysis (solvent system:
EtOAc). THF was removed in vacao and water (20m1 ) was added, extracted with EtOAc (3 x 30m1). The combined EtOAC layer was washed with water (2 x 10 ml), brine (2 x s lOml) and dried over anhydrous Na2S04. Concentration in vacuo afforded 5.409 gm of the crude product. This was further purified by flash chromatography over a column of silica gel (350 gm, 200-40(? mesh). The desired product was obtained in EtOAc eluate as a pale brown oiI ( 1.94 gm, 5.10 mmols), 51 % yield based on the starting (R) eonone:
Rf 0.5 (solvent system EtOAc). This was dissolved in anhydrous ethyl acetate (50 ml) and to this io was added 0.400 gm of the activated charcoal and stirred in an atmosphere of nitrogen at RT for 1 hr. This solution was filtered over celite bed using a G-4 sintered funnel, washed with EtOAc (30 ml): Removal of volatiles in vacuo afforded 1.95 gm of the crude product, which was purified by flash chromatography over a column of silica gel ( 150 gm, 200-400 mesh) and the desired product was obtained in ethyl acetate eluate as a colourless viscous ~s oil, which solidified on storing at -22°C as a colourless solid (chloroform-methanol gradient system can also be used for the flash chromatographic purification).
Yield: 1.90 gm, 5 mmols 50%. 1H NMR (CDCI3): 8 0.85 (t, 3H, J = 6.8 Hz); 1.1-1.5 (m, 8H);
1.6-1.9 (m, 7H); 2.1-2.5 (m, lOH); 3.65 (s, 3H); 3.85-4.0 (bs, 1H); 4.3-4.4 (bs, 1H) 5.3-5.6 (m, 2H): 13C NMR (CDCI3): 8 173.64, 139.50, 127.92, 79.56, 79.48, 77.2, 72.28, 72.02, 20 54.53, 51.4, 48.84, 42.56, 42.0, 32.69, 32.0 26.51, 23.87, 23.68, 22.35, 17.98, 16,97 and 13.78.
Note For the desilylation reaction it is essential to use anhydrous TBAF in THF. Use of TBAF.3 H20 does not give the desired product in good yield.
Preparation of carboprost methyl ester, (15S)-15- Methyl PGFZa methyl ester or IUPAC nomenclature as mentioned in USP as Prosta-5,13-diem-1-oic methyl ester, 9,11,15-trihydroxy-15-methyl-(5Z,9a,11a,13E,15S) or (Z)-7-[1R,2R,3R,SS)-3-5-Dihydroxy-2-[(E)-(3S)-3-hydroxy-3-methyl-1-octenyl]cyclopentyl]-5-heptenoic methyl 3o ester.
Selective Lindlar hydrogenation was performed in batches of 0.500 gm up to 1 gm scale.
The following procedure is representative.
3s A precooled 2-necked 1000 ml r.b. flask was charged with the desilylated product ( 1.065 gm, 2.80 mmols) and to this was added a preformed mixture of benzene ( 100 ml) and cyclohexane (300 ml) by means of a cannula under nitrogen. To the reaction mixture was added 0.315 gm of Pd over CaC03 poisoned with lead under nitrogen. The reaction mixture was evacuated in vacuo and flushed with hydrogen gas and through the reaction mixture was bubbled hydrogen gas while stirring at a rate of 45 bubbles per minute over a s period of 90 min: An aliquot was taken out at regular time intervals and the progress of the reaction was monitored by 13C NMR analysis (approx. 1.5 hrs, 13C NMR analysis should indicate the total disappearance of alkynyl carbon at 8 80 ppm). The reaction mixture was filtered using a G-4 sintered funnel, the residue washed with EtOAc. (The catalyst recovered could be recycled). Concentration of the organic phase in vacuo furnished the ~o desired carbonprost methyl ester as a viscous colourless oil ( lg). This was further purified by chromatography over silica gel in EtOAc eluate (chloroform-methanol gradient system can also be used for the flash chromatographic purification). 1H NMR (CDCI3 :
8 0.85 (t, 3H, J ~ 6.8 Hz); 1.1-1.5 (m, 8H); 1.6-1.9 (m, 7H); 2.1-2.5 (m, lOH); 3.65 (s, 3H); 3.85-4.0 (bs, 1H); 4.3-4.4 (bs, 1H); 5.3-5.6 (m, 4H): 13C NMR (CDCI3): 8 173.79, 139.0, 129.26, is 129.0, 128.5, 77.9, 72.6, 72.5, 55.6, 51.4, 50.4, 42.58, 33.16, 32.03, 27.23, 26.33, 25.29, 24.55, 23.62, 22.4 and 13.82.
This product was further purified by preparative reversed phase HPLC using a preparative ODS (C-18) SHIMPAK column (20 x 250 mm) and using a mobile phase of acetonitrite-2o water ( 1:1 ): UV detection: 210 nm. The preparative HPLC was done in batches of 0.170 gm and the recovery of the pure carbonprost methyl ester of USP specifications was --65%.
Suitably Rl and R2 are both hydrogen or together form a bond such that the groups ORS
and R2 form a carbonyl group. Preferably RI and R2 are both hydrogen.
The groups P and Pl, which can be the same or different, can be any suitable oxygen protecting groups, for example tetrahydropyran and, in particular, silyl protecting groups such as t-butyldiphenylsilyl, dimethylphenylsilyl, triethylsilyl, t-butyldimethylsilyl (TBDMS), trimethylsilyl (TMS) and triisopropylsilyl . Preferably P is TBDMS
and P~ is ~o TMS.
The reaction of compounds of formula (II) and (III) is carried out in a suitable solvent such as THF-hexane, THF-ether, preferably THF/ether. Preferably the reaction is carried out at reduced temperature, for example at about -78°C. Preferably the reaction is carried out in is the presence of a Lewis acid, particularly in the presence of BF3.OEt2. It has been found that the use of BF3.OEt2 not only activates the enone at low temperatures and drives the reaction to completion, but also circumvents the problem of dehydration at the position. The higher order cuprate of formula (III) is preferably generated using anorgano-lithium reagent, preferably butyl lithium.
Reduction of a compound of formula (IA) can be carried out using known reducing agents.
For example reduction of the cyclopentanone is preferably carried out using a selective reducing agent such as K-selectride to give the desired cyclopentanol isomer.
Reduction of the triple bond can be carried out using conventional techniques such as Lindlar 2s hydrogenation.
Removal of protecting groups can be carried out using conventional procedures.
For example when protecting groups P and Pt are both silyl groups deprotection of both groups can be achieved using a fluoride reagent such as TBAF in a suitable solvent such as 'TIC.
3o Preferably the cyclopentanone moiety is reduced, followed by deprotection of the groups P
and Pl followed by reduction of the triple bond to furnish the desired compounds of formula (1).
Compounds of formula (II) can be prepared from compounds of formula (IV):
O
L
PO (N) in which P is as defined in formula (II) and L is a leaving group with a compound of formula (V}:
Hal-CH2 (CH2)3 C02Me (V) in which Hal is halogen in the presence of an organolithium reagent.
Preferably L is a group such as a -SaPh to stabilise the carbanion generated and Hal is bromo or iodo, io preferably iodo.
Compounds of formula (IV} in which L is SePh can be prepared from the corresponding enone and phenylselenyl chloride using literature procedures. The enone can be prepared by protecting the corresponding alcohol, for example by treating with TBDMS
chloride is conventional conditions.
Compounds of formula (V) can be prepared by halogenation of the con~esponding alcohol which in turn is prepared using known procedures as exemplified herein.
zo The compound of formula (~ is a suitable cuprate, in particular a higher order cuprate and preferably a thienyl cuprate, in particular dilithium [3-methyl, 3-(trimethylsilyl~xy octyl}-2-thienyl cyanocuprate of formula (BIA):.
~N
Cu ~ CsH» Li2 S
OP
2s which is prepared from the corresponding halide of formula (Vn:
Hal / CSH»
.:
OP' in which Hal is halogen, in particular iodo, and PI is a protecting group as defined in formula (III), preferably aTMS group. This compound can be prepared according to the procedures exemplified herein.
Novel intermediates form a further aspect of the invention.
The invention is illustrated by the following Examples.
Intermediate 1 a) Methyl-7-hydroxy hept-5-ynoate.
s The title compound was prepared according to the method of R.J.K. Taylor et al., Tetrahedron, 42, 5849-56 (1986) as an oil, by 130 - 132°C at O.Smm Hg.
1H NMR (CDCI3): 8 4.I5 (m, 2H), 3.6 (s, 3H), 3.0 (bs, IH, exchanges with D20), 2.35 (t, 2H), 2.25 (t, 2H) and I.75 (q, 2H).
~o b) Methyl-7-iodo hepta-5-yonate:
The title compound was prepared from the above a-alcohol according to the method of Carl Johnson et al., JACS,110, 4726-35 (1988) as an oil, by 110 - 113°C
at 0.9 mm Hg.
~s 1H NMR (CDCI3~: b 3.6 - 3.7 (bs,SH), 2.4 (t, 2H), 2.25 (t, 2H), 1.75 (q, 2H).
Intermediate 2.
SYNTHESLS OF RAGEMIC 4-HYDROXY CYCLOPENTENONE.
The title compound was prepared according to the method of M. Minai, Jap.
Patent., Kokai No. 62236,1982.
1H NMR (CDCI3); 8 7.55 (dd, J = 6Hz, I.SHz, 1H), 6.2 (d, J = 6 Hz, 1H), 5.05 (m, IH), 2s 2.75 (dd, J = 17 Hz, 6 Hz, 1H), 2.25 (dd, J = 17 Hz, 6 Hz, 1H) and 2.0 (bs, 1H, exchanges with D20).
Intermediate 3 Synthesis of 1-lodo(S)-methyl-3-(trimethylsilyloxy)-oct-2-ene.
a) Racemic 3-methyl-octa-1-yn-3-of A 3-necked 3litre r.b. flask was cooled under a stream of nitrogen gas and was fitted with mechanical stirrer through the centre neck. Side arm was connected to a socket with gas 3s inlet and a cold, finger condenser. Another side arm was connected to a nitrogen inlet under static pressure. The cold finger condenser was charged with dry ice-acetone mixture (-78°C) and the reaction flask was kept in an insulated bath. Anhydrous ammonia gas (dried through a wash bottle containing KOH pellets) was bubbled at a steady rate through the gas inlet in an atmosphere of nitrogen, whereupon ammonia condenses into the reaction flask. It took around 2 hr. to condense ammonia gas to obtain around 1.6 Litre of liquid s ammonia. At this stage the condensation of ammonia was stopped and in the place of ammonia bubbler was connected the nitrogen inlet. The other side arm was stoppered.
Sodium metal was cut into small pieces and washed with anhydrous hexane. After the addition of the first piece while stirring mechanically, the colour of the reaction mixture turned blue as the metal dissolved. As soon as the blue colour persists, ferric nitrate was io added through the side arm, whereupon the reaction becomes exothermic and upon stirring the blue colour discharges to afford the greyish white sodium amide. The addition of sodium metal was continued. Upon addition of sodium metal, the appearance of blue colour was observed and as the stirring is continued, the greyish white coloration is observed. After the complete addition of the metal (it took 1 hr. for the completion of is addition of sodium metal), the reaction mixture was stirred for about 0.5 hr to ensure the complete formation of sodium amide. During the whole process a static pressure of nitrogen gas and the temp. of -78°C in the cold finger condenser was maintained. Through one side arm, a gas inlet tube was inserted and bubbling of acetylene gas was continued at a steady rate (acetylene was bubbled through a paraffin trap and an empty trap kept at -78'C) 20 over a period of 5 hr. to ensure the complete formation of sodium acetylide. Acetylene bubbling was stopped and a pressure equalising dropping funnel was fitted to one side arm of the reaction flask and was charged with 2-heptanone (287g, 2.511 mol) in anhydrous ether (75 ml). The contents were then added dropwise while stirring over a period of 1 hr.
(exothermic reaction!). The dropping funnel was rinsed with ether {40 ml) and the is washings were added to the reaction flask. The contents in the reaction flask were stirred vigorously and the bubbling of acetylene gas was continued for another 3 hr.
and allowed to stand overnight without stirring. The temp. in the cold finger condenser was raised to ambient temp. slowly the facile evaporation of ammonia gas.
3o Workup: The mechanical stirrer and the cold finger condenser was dismantled and the 3-necked flask was cooled to 0°C under nitrogen using an ice-bath and to this was added NH4CI solution in water in small lots of 50 ml each. The reaction mixture was stirred at 0°C for a further 0.5 hr. and warmed to RT and stirred at RT for 2 hr.
The resultant solution was filtered over a celite bed using a G-3 sintered funnel. The residue was washed ss with pet ether (2 x 150 ml). The contents were transferred to a separatory funnel and the aqueous layer was separated. Aqueous layer was extracted with pet ether (3 x 500 ml).
Combined PE portion was washed with water (2 x 500 ml), brine ( 100 ml) and dried over anhydrous Na2SO4. Removal of volatiles in vacuo afforded 352 gm of crude ~i-chain alcohol. This was further purified by distillation in vacuum (bp 76-78°C at 17mm of Hg) to get 330 gm of (3-chain alcohol (2.360 Mols, 94% yield). Initial forerun in the distillation s furnished unreacted 2-heptanone (bp. 67-69°C at l7mm of Hg). This was recycled with next batch for the preparation of racemic octynol.
Yield of racemic (3-chain alcohol: 330 gm, 2.360 mols, 94%. Purity of > 99%
was ascertained by GC analysis: column: OV-101, 90pC, RT for octynol: 5 min: for heptanone:
io 2.5 min.).
b). 3-Methyl-3-carboxy-oct-1-yn-3-of hydrogen phthalate.
i). Recrystallisation of phthalic anhydride - representation procedure.
is A precooled 5 litre r.b. flask with a magnetic stirring bar was charged with 570 gm of phthalic anhydride and 2.3 litre of chloroform. The contents were refluxed on a water bath for 0.5 hr and filtered hot on a sintered funnel. Undissolved residue is phthalic acid. The filterate was left in the refrigerator in a tightly stoppered flask to get the crystalline phthalic 2o anhydride. This was filtered, washed with hexane and dried in a desiccator.
mp 130-131°C.
ii) 3-Methyl-3-carboxy-oct-1-yn-3-of hydrogen phthalate.
is A pre-cooled 5 litre r.b. flask with a magnetic stirring bar was charged with the racemic octynol (0.92kg, 6.57 mol), phthalic anhydride (0,979kg, 6.606 mol), DMAP
(O.O8kg, 0.658mo1) and triethylamine (0.67kg, 6.617mo1). The reaction mixture was refluxed at 80°C for 6 hr and allowed to cool to RT and stirred overnight. The progress of the reaction was monitored by TLC (solvent system: 20% EtOAc in PE) for the disappearance of the so starting octynol. The reaction mixture was left overnight at RT.
Worlcup: A 20 Litre r.b. flask with a flange and a mechanical stirring assembly was charged with 7.4 Litre of water and 0.731 litre of cone. HCI and cooled to OpC
using an ice bath. To this mixture was added the hemiphthalate reaction mixture while stirring, 3s followed by the addition of chloroform (2.3 litre). The stirring was continued for 1 hr. The organic layer was separated and the aqueous layer was extracted with chloroform (3 x 3 litre). Combined organic layer was washed with water (2 x 500 ml) and brine (500 ml).
This was dried over anhydrous Na2S04 and volatiles were removed using a rotary evaporator and dried in high vacuum.
s In another 20 Litre r.b. flask with a flange and a mechanical stirring assembly was taken petr. ether S.5 Litre) and cooled to 0°C. Hemiphthalate from the earlier step was poured into PE while stirring and stirred for 1 hr., whereupon the desired hemipthalate ester crystallises. This was filtered using a buchner funnel, residue washed with cold PE (500 ml) and dried in suction. This residue was air dried (m p 61-62°C, 0.915 Kg,). The mother io liquor from filitration was concentrated in vacuo using a rotary evaporator and kept in the refrigerator to get an additional lot of hemiphthalate ester (2"d crop, 0.43 Kg, m p 61-62°C). However, by repeating the sequence for the third crop, the compound obtained (0.1 S 1 Kg) showed higher m p and hence was kept aside and taken up for the recovery of racemic octynol.
a Yield of hemiphthalate ester: 1.348 Kg, 71 %.
c). Brucine phthalate of 3-Methyl-oct-1-yn-3-ol.
A pre-cooled 20 litre flanged r.b. flask with a mechanical stirnng assembly was charged with the hemiphthalate ester of racemic octanol (0.94kg, 3.262 mol), brucine ( 1.432kg, 3.327 mol) and anhydrous acetone (3.751). The reaction mixture was heated at SOPC for 1 2o hr and allowed to cool to RT and stirred overnight at RT.
Wockup: The precipitated solid was filtered using a buchner funnel and washed with cold acetone (2 x 250 ml) to get rid of the contamination of undesired diastereomer. The resulting solid was air dried.
Yield: 0.739 Kg, 1.028 mols, 31.5°!0. m p 158-159°C, [a]D = -12.0° t 0.5(c 0.88, EtOH).
zs The mother liquor was kept aside for the recovery of brucine.
d). Hemiphthalate ester of (S)-octynol from brucine salt: (S)- 3-Methyl-3-carboxy-oct-1-yn-3-of hydrogen phthalate.
3o A pre-cooled 20 litre flanged r.b. flask with a mechanical stirring assembly was charged with brucine salt (0.827kg, 1.15 mol) and ether (8.21). To this was added conc. HCI (0.83 1) in small lots at 0°C while stirring. The reaction mixture was stirred at 0°C for 2 hr and allowed to warm to RT.
Workup: The contents were transferred to a separatory funnel and the ether layer was separated. Aqueous layer was extracted with ether (2 x 500 ml). Combined ether layer was washed with water (2 x 250 ml), brine (250 ml) and dried over anhydrous Na2S04.
s Removal of volatiles in vacuo afforded the desired hemipthalate ester of (S)-octynol as a viscous material. The aqueous layer was discarded.
Yield of hemiphthalate ester of (S)-octynol: 0.332 Kg (near quantitative).
This was used as such without purification for further reaction.
~o e). (S)-3-Methyl-oct-1-yn-3-ol.
A pre-cooled 20 litre flanged r.b. flask with a mechanical stirring assembly and a reflux condenser was charged with the hemiphthalate ester of (S)-octynol (0.332 kg, 1.151 mol) and to this was added NaOH solution (0.504 kg in 3.61 water} at RT. The reaction mixture ~s was refluxed on a water bath for 2 hr. The reaction mixture was cooled to RT, whereupon the octynol layer separates. The contents were transferred to a separatory funnel and the supernatent layer was separated. The aqueous layer was extracted with petroleum ether (3 x 500 ml) and mixed with the octynol fraction. Combined organic portion was washed with distilled water (3 x 500 ml) till the pH is 7. The organic portion was dried over 2o anhydrous Na2S04 and removal of volatiles furnished 155 gm (96%) of crude (S)-octynol which was further purified by distillation in vacuo. b p. 73-76°C at 14-15 mm of Hg.
Yield: 128.87 gm, 0.921 mols, 80%, [a]D = -2.3° t 0.5(c 2.7, EtOH).
Reported [a]D =
2.33° (c 2..625, EtOH).
f7. (S)-3-Methyl-3-(trimethylsilyl~xy-oct-I-yne.
a A pre-cooled 1 litre r.b. flask with a magnetic stirring bar was charged with (S}-octynol (29g, 0.207 mol) and DMF. The reaction mixture was cooled to 0°C (ice-bath) under nitrogen atmosphere. To the reaction mixture was added imidazole (39.44g, 0.58 mol) in small portions (of - 5 gm) at 0°C and stirred to 15 min. To the reaction mixture was 3o added TMS chloride ( 33.72g, 0.310 mol) dropwise by means of a syringe over a period of 45 minutes and then stirred at 0°C for 1 hr. The reaction mixture was allowed to warm to RT and stirred at RT overnight. The progress of the reaction was monitored by TLC
(solvent system: 10% EtOAc in petroleum ether) for the disappearance of the starting alcohol.
Workup: The reaction mixture was poured into ice water (750 ml) and extracted with ether. The supernatent ether layer was separated and the aqueous layer was extracted with ether (3 x 250 ml). Combined organic portion was washed with water (2 x 100m1) and brine (50 ml). This was dried over anhydrous Na2S04 and volatiles were removed using a s rotary evaporator and dried in high vacuum. This was purified by distillation under reduced pressure to get the title product:
bp. 87-90°C at 12-15 mm of Hg.
Yield: 35.09 gm, 165.5 mmols, 80%.
~o g). (S)-3-Methyl-3-(trimethylsilyl)oxy-1-(n-tributylstannyl)-oct-1-ene (E).
A pre-cooled 500 ml r.b. flask with a magnetic stirring bar was charged with TMS ether of (S)-octynol 7.SOg, 35.37 mmol), TBTH ( 16.31 g, 35.4 mmol) and AIBN (0.4g, 2.47 mmol).
The reaction mixture was evacuated and flushed with nitrogen gas. The flask was then immersed in a preheated oil-bath at 130°C, whereupon a vigorous initiation reaction took is place with the evolution of hydrogen gas. (a suitable vent is desirable).
The reaction mixture was heated in an oil bath at 150°C for 3 hr and cooled to RT
under nitrogen atmosphere. To the reaction mixture was added petr. ether (150 ml) and allowed to stir at RT for 15 min. The reaction mixture was filtered over a celite bed using a G-3 sintered funnel. The residue was washed with anhydrous PE (60 ml) and the combined PE
layer, zo upon removal of volatiles afforded desired stannane derivative in quantitative yield.
Note: This derivative was stored in a tightly stoppered flask covered with an aluminium foil, under nitrogen. This is highly moisture and light sensitive! Large scale preparation would involve mixing of reactants followed by the addition of AIBN, once the operation temperature is attained.
zs h) 1-Iodo (S)-3-methyl-3-(trimethylsilyoxy)-oct-2-ene.
A pre-cooled 500 ml r.b. flask with a magnetic stirring bar was charged with stannane derivative (61.06g, 0.121 mol) and to this was added freshly distilled THF ( 170 ml). The reaction mixture was cooled to -78°C using dry ice-acetone bath and to this was added a 3o solution of N-iodo succinimide (27.31 g, 0.121 mol) in THF ( 100 ml) by means of a cannula at -78°C under nitrogen over a period of 45 min. The reaction mixture was stirred at -78°C for 1 hr. The temp. of the bath was gradually raised to RT and stirred at RT for 15 min. The progress of the reaction was monitored by TLC (solvent system: Petr.
ether) for the disappearance of starting material.
WO 99/44990 PC"T/SE99/00318 Workup: The reaction mixture was poured over ice and filtered over celite bed using a G-3 sintered funnel. The filitreate was extracted with PE (4 x I00 mI). Combined PE layer was washed with water ( 100 ml), 10% sodium thiosulphate solution ( 150 ml) and finally s with water (SO mI): PE portion was dried over anhydrous Na2S04 and removal of volatiles in vacuo afforded desired iodide (0.072 Kg). This was purified by high vacuum distillation (bp.79-82°C at 0.1 mm of Hg, 0.040 Kg, 0.118 Mols, 97%.
[a]D = -24.0° ~ 0.5(c, 1.61: CHCI3): reported [a]D = -22.5° (c, 1.2: CHCI3).
~ o Intermediate 4 Preparation of 4-[(tert-butyldimethylsilyl)oxy]-2-cyclopenten-1-one.
Prepared according to the method of R. Noyori., et al., Tetr. Lett., 28, 4719-20 (1987) from 4-hydroxycyclopentanone (intermediate 2, 10.1 g, 0.103 mmol}, 4-DMAP ( 1.21 g, is 0.00993 mol) and triethylamine (11.46g, 0.113 mmol).
Yield: 24.03 gm (pale brownish in colour). The material had some colouring impurities which were removed via distillation under reduced pressure. (bp. 82-86°C at lmm of Hg).
Yield of the desired product: 20.02 gm, 0.158 mots, 91.7%.
2o iH NMR (CDCI3); 8 7.4 (m, d, 1H), 6.1 (d, 1H), 4.9 {m, 1H) 2.6 (dd, 1H), 2.15 (d, 1H), 0.8 (s, 9H), 0.1 (s, 6H). The purity of the material was established by HPLC
using a chiracel-OD column using 1.5% isopropan-2-Ol in n-hexane.
Intermediate 5 as a) Preparation-of racemic 4-[(t-butyldimethylsilyl)oxy)-2-(phenylseleno)-2-cyclopenten-1-one Prepared according to the method of T. Toru, et al., J.Org. Chem., 57, 4719-20 (1992) from TBS-derivative 4-[(tert-butyldimethylsilyl~xy]-2-cyclopenten-1-one.
30 (23.84g, 0. I 12 mol), phenyl selenyl chloride (32.32g, 0.169 mol) and pyridine ( 14.69g, 0.186 mol).
Yield 37.14g, 90%.
1H NMR (CDCI3): 8 7.3-7.7 (m, SH), 4.85 {m, 1H}, 2.8-2.9 (dd, 1H) 2.35 (d, 1H), 0.8 (s, ss 9H) and 0 (s, 6H).
b). Preparation of Methyl 7-(3-Hydroxy-5-oxo-1-cyclopentene-1-yl)-5-heptynoate via a two-component coupling process.
s Prepared according to the method of T. Toru, et al., J.Org. Chem., 57, 3145-3152 (1992) from selenyl derivative 4-[(tert-butyldimethylsilyl~xy]-2-(phenylseleno)-2-cyclopenten-1-one.
(16.658, 45.3 mmol), bis(tributylstannane (28.948, 49.91 mmol), n-BuLi (35.6 ml of 1.4M
in hexane, 49.91 mmol), iodine (25.358, 95.28 mmol) and HMPA (26m1) in THF.
~o The product was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether. Yield of the pure product: 11.11 gm, 31.76 mmols, 70°k.
1H NMR (CDCI3); b 7.3 (s, 1H), 4.9 (m, 1H), 3.65 (s, 3H), 3.0 (bm, 3H), 2.75 (dd, 1H) is 2.45 (t, 2H), 2.25 (bt, 2H), 1.8 (q, 2H), 0.8 (s, 9H) and 0.1 (s.6H).
c). Methyl 7-(3-Hydroxy-5-oxo-1-cyclopentene-1-yl)-5-heptynoate Prepared according to the method of E.J. Corey et al, JACS., 94, 6190-91 (1972) from the zo TBS derivative (6.028, 17.22 mmol) , Methyl-7-[-3-tert butyldimethylsilyl~xy]-5-oxo-1-cyclopenten-1-yl]-kept-S-ynoate in a solution of AcOH: THF: water (3:1:1).
Yield 2.44 gm, 10.33 mmols, 60%. TLC: solvent system: 70% EtOAc in petroleum ether.
1H NMR (CDCI3); $ 7.4 (bs, 1H), 5.0 (bs, 1H), 3.65 (s, 3H), 3.0 (bm, 3H), 2.85 (dd, 1H) zs 2.45 (m, 2H), 2.25 (m, 2H), and 1.8 (q, 2H).
d) ENZYMATIC IRREVERSIBLE TRANSESTERIFICATION USING Lipase IN
VINYL ACETATE IN A SONICATOR BATH:
Prepared according to the methods of K.A. Babiak, et al., J. Org.Chem., 55, 3377-81, so (1990) and G Lin, et al., Tetr.Lett., 36, 6067-68 (1995) from the hydroxy-enone (4.78, 19.91 mmol, Methyl-7-[(3-hydroxy)-S-oxo-1-cyclopentene-1-yl]-hept-5-ynote and PPLipase and/or HPLipase (crude, 7.Sg) in vinyl acetate with sonication.
Yield of desired acetate 2.408, 43%.
1H NMR (CDCI3); 8 7.4 (bs, 1H), 5.75 (m, 1H), 3.65 (s, 3H), 3.05 (bm, 3H), 2.85 (dd, 1H), 2.4 (t, 2H), 2.25 (m, 2H), 2.1 (s, 1H) and 1.8 (q, 2H).
e} DEACETYLATION USING GUANIDINE IN METHANOL
s Preparation of a stock solution of Guanidine in Methanol:
Prepared according to the method of K.A. Babiak, et al., J. Org.Chem., 55, 3377-81, (1990) from guanidine carbonate (28.48, 0.158 mol), sodium metal (3.56g, 0.155 mol) in methanol (0.3081).
io Methyl-7-(((R)-3-hydroxy)-5-oxo-1-cyclopentene-1-yl]-kept-5-ynote.
Prepared according to the method of : K.A. Babiak, er al., J. Org.Chem., 55, 3377-81, (1990) from the (R) acetate ( 1.905g, 6.85 mmol) and guanidine in methanol.
is Note: it is recommended to carry out the deacetylation on a small scale before performing deacetylation on a rather big scale because of the sensitive nature of (3-hydroxy ketone.
Yield: 1.130 gm, 4.788 mmols, 70% yield, (90 optically pure). This was used for further 2o upgradation of optical purity using PPLipase and/or HPLipase as described below.
Procedure: Same as the earlier enzymatic resolution using a sonicator bath.
Enrichment was complete in 5 days. Desired product was isolated by flash chromatography in 40-50%
EtOAc in PE eluate. Yield of (R)-Acetate: optical purity: > 99.9%. This was further 2s deacetylated using guanidine in methanol to get 1.553 gm of optically pure alcohol (5.586 mmols, > 99.9% optically pure by chiral HPLC analysis.
f) MITSUNOBU INVERSION TO CONVERT UNDESIRED ENANTIOMER TO
THE DESIRED ENATIOMER:
Prepared according to the methods of K.A. Babiak, et al., J. Org.Chem., 55, 3377-81, (1990).
A precooled 250 ml. flask with a septum inlet and a magnetic stirring bar was charged with (S)-alcohol (2.S8g, 10.93 mmol of 88% optical purity), Ph3P {5.74g, 21.86 mmol) and 3s freshly distilled THF. The reaction mixture was cooled to 10°C and to this was added formic acid by means of a syringe, followed by the addition of diisopropylazodicarboxylate (DIAD, 4.42g, 21.86 mmol) and slowly warmed to RT. The pale yellow reaction mixture was stirred at RT for 12 hr. in an atmosphere of nitrogen gas. The progress of the reaction was monitored by TLC (solvent system: 70% EtOAc in PE).
s Worlcup: The solvent was removed in vacuo under pressure using a rotary evaporatorand the resulting brownish residue was dissolved in ether (70 ml) and triturated with n-hexane ( 16S ml) to precipitate phosphorous salts. The mixture was stirred at RT for 30 min. and filtered over a G-3 sintered funnel, washed with ether (2 x SO ml). Combined organic portion was transferred to another r.b. flask and volatiles were removed in vacuo using a io rotavapor. The resulting residue was dissolved in MeOH (120 ml) and to this was added alumina (activated, neutral, 100 gm) and stirred at RT overnight. The progress of the reaction was monitored by TLC (solvent system: 70% EtOAc in PE). The reaction mixture was filtered on a G-3 sintered funnel and the residual alumina was repeatedly washed with MeOH (3 x 10(? ml), combined filterate was subjected to flash evaporation is using a rotary evaporator to give 13.805 gm of the crude product. This was further purified by flash chromatography over a column of silicagel (400 gm, 200-400 mesh).
Initial elution with a gradient of 1S-60% EtOAc in petroleum ether gave undesired 1,2-diisopropyl dicarboxyhydrazine and the desired alcohol was obtained in 80-9S%
EtOAc in PE. The HPLC analysis using Chiracel-OD column indicated clean inversion at the chiral 2o centre (no noticeable racemisation) with an optical purity of 88% of the (R) isomer.
This product was further subjected to enzymatic transesterfication using HPL
in a sonicator to furnish desired (R)-acetate of >99% optical purity. Yield: 1.891 gm, 6.802 mmols, 70%. This was further deacetylated using guanidine in methanol, to get the desired as (R)-alcohol in > 99% optical purity. Yield: 1.166 gm, 4.94 mmols, 73%
yield.
g). Methyl-7-[(R)-3-tert-butyldimethylsilyl)oxy]-5-oxo-1-cyclopenten-1-yl]-hept-5-ynoate.
3o To a precooled 2S0 ml r.b. flask with a septum inlet and a magnetic stirring bar was taken TBDMS chloride ( 1.90g, 12.64 mmol) and dichloromethane. The solution was cooled to 0°C using an ice-bath and to this was added imidazole ( 1.60g, 23.66 mmol) in one portion, followed by the addition of DMF. The reaction mixture was stirred at 0°C for 1 S min. In another pre-cooled flask was taken (R)-enone alcohol ( 1.99g, 8.4 mmol) in anhydrous 3s CH2CIz (3 ml) and this was transferred to the reaction flask under nitrogen by means of a cannula. The washings ( 1 mI) were transferred to the reaction flask and stirred at 0°C for 2 WO 99/44990 PC'T/SE99/00318 hr. The reaction mixture was allowed to warm to RT and stirred further overnight (- 10 hr.). The progress of the reaction was monitored by TLC (solvent system:
petroleum.ether:EtOAc, 3:7).
s Workup: The reaction mixture was poured over ice-water and extracted with dichloromethane (3 x 100 ml). Combined organic layer was washed with water (30 ml) and with brine. Organic portion was dried over anhydrous Na2S04, removal of voladles in vacuo furnished 3.80 gm of oily material, which was further purified by flash chromatography on a column of silica gel ( 150 gm, 200-400 mesh) in 15-25%
EtOAc in to pet. ether eluate. Yield of the desired product: 2.90 gm, 4.66 mmols, 70%.
TLC: solvent system: 70% EtOAc in petr. ether.
1H NMR (CDCI3); 8 7.4 (bs, 1H), 5.0 (bs, 1H), 3.65 (s, 3H), 3.0 (bm, 3H), 2.85 (dd, 1H), 2.45 (m, 2H), 2.25 (m, 2H) and 1.8 (q, 2H). The purity of the material was established by is HPLC using a chiracel-OD column using 7% isopropan-2-of in n-hexane.
Example 1.
a). 2-ThienylUt6ium Procedure: In a pre-cooled 100 ml r.b. flask with a septum inlet and a magnet stirring bar was taken freshly distilled THF (30 ml) and thiophene ( 1.59 ml, 20 mmols).
The reaction mixture was cooled to -60°C (dry ice-CHCI3 bath) and to this was added n-BuLi ( 16.7 ml, 1.2M in hexane) dropwise by means of a syringe over a period of 15 min. The reaction zs mixture was stirred at -60°C for 1 hr. to ensure the completion of metallation. The colour of thienyllithium in THF was pale yellow.
b) Preparation of vinyllithium:
so Procedure: A pre-cooled 100 ml r.b. flask with a septum inlet and a magnetic stirring bar was charged with B-chain iodide TMS ether (6.8g, 20 mmol) in 30 ml of THF
(freshly distilled, anhydrous) and the contents cooled to -78°C {dry ice-acetone bath) under nitrogen. To this was added n-BuLi (21 mmol, 17.5 ml) dropwise by means of a syringe at -78°C over a period of 30 min. The reaction mixture became turbid with pale yellow ss precipitate of vinyllithium indicating the completion of reaction. The contents were further stirred at -78°C or 1 hr.
c) TWO-COMPONENT COUPLING PROCESS:
Procedure: To a precooled 500 ml r.b. flask with a septum inlet was added Cu(I)CN (20 s mmol, 1.79gm) and a magnetic stirring bar. The flask was capped with a rubber septum and heated with a heat gun under high vacuum to remove any traces of moisture, allowed to cool and purged with nitrogen. THF (30 ml) was added and the suspension cooled to -22°C (dry ice-CCI4 bath) under nitrogen. To this was added the solution of preformed 2-thienyllithium (step a) dropwise by means of a cannula over a period of 10 min. The ~o contents were washed with THF (5 ml) and added to the flask, whereupon the solution became homogenous (pale yellow colour) to afford the desired lower order cuprate. The reaction mixture was further stirred at -22°C for 1 hr.
To the above solution of the lower order cuprate was added the solution of vinyl lithium ~s (step b) dropwise by means of a cannula over a period of 10 min at -22°C, washed with THF (5 ml) and the solution stirred at -22°C for a further 1 hr. to provide a homogenous higher order cuprate (clear solution, pale yellowish orange colour). The resulting cuprate solution was cooled to -78°C (dry ice-acetone bath).
2o In a precooled 100 ml pear shaped flask was taken (R)-enone TBDMS ether (>
99%
optically pure, 3.5 gm, 10 mmols) and to this was added anhydrous ether (40 ml) by means of a syringe. The contents were cooled to -78°C using a dry ice-acetone bath for 10 min.
To this was added BF3:OEt2 ( 1.29 ml, 10.5 mmols) dropwise while stirring, by means of a syringe at -78°C and left at this temp. for 5 min. This solution was then added dropwise 2s (very slow dropwise addition!) to the solution of the higher order cuprate (obtained in step-c) at -78°C under nitrogen by means of a cannula over a period of 45 min. The flask of enone was washed with ether (Sml) and the washings transferred to the reaction flask over a period of 45 min. The stirring was continued at -78°C for 1.5 hr (progress of the reaction monitored by TLC, solvent system: pet. ether -10% EtOAc, for the disappearance of the 3o starting enone). The reaction mixture was quenched with saturated aqueous ammonium chloride solution (20 ml) at -78°C and warmed to RT. The reaction mixture was poured into a mixture of 150 ml distilled water and 300 ml of ether. The aqueous layer was extracted with ether (3 x 100 ml) and the combined organic portion was washed with brine, dried over anhydrous Na2S04. Removal of volatilities in vacuo afforded an oil ( 11.35 ss gm). This product was used as such for the further sequence without chromatographic purification. TLC: solvent system: pet ether-10% EtOAc: A part of the sample was purified by flash chromatography (silicagel, 1:20 ratio, 200-400 mesh) and the desired product was obtained in 20% EtOAc in PE eluate for characterisation, Rg 0.31, solvent system: pet.ether-10% EtOAc:
IH NMR (CDCI3): b 0.05 (s, 6H); 0.8-0.9 (m, 12H); 1.1-1.6 (m, lOH); 1.7-1.8 (m, 3H);
s 2.0-2.3 (m, 6H); 2.4 (t, 2H, J = 7.4 Hz); 2.6-2.9 (m, 3H); 3.65 (s, 3H); 4.1 (m, 1H); 5.3-5.5 (m,2H).
Example 2.
(5,6-Didehydro-11-O-(tert-butyldimethylsilyl)-15-O-(trimethylsilyl-13-(S)-methyl -i o PGF~ methyl ester Procedure: To a flame dried 250 ml r.b. flask with a septum inlet and a magnetic stirring bar, was added the crude TCC product [5,6-Didehydro-11-O-tent butyldimethylsilyl)-15-O-(trimethylsilyl)-13-(5~-methyl - PGE2 methyl ester]. (11.35 gm, from 10 mmol of the ~s enone) in THF (anhydrous, 35 ml). The solution was cooled to -78°C
and treated with a solution of K-selectride (32.85 ml, 30 mmol, 0.9M solution in THE dropwise by means of a syringe. The reaction mixture was allowed to stir at -78°C for 1.5 hr. and to this was added dropwise a 30% aqueous solution of H202 (4.54 ml, 40 mmol). Stirring was continued for another I S min, the cooling bath was removed and the reaction mixture Zo warmed to room temperature. Water (20 ml) was added and the organic phase separated.
The aqueous phase was extracted with EtOAc (3 x 50 ml). The combined organic layer was washed with brine (2 x 20 ml) and dried over anhydrous Na2S04. Removal of solvent in vacue furnished 13.516 gm of the desired crude product. This was used as such for further desilylation. TLC solvent system: 20% EtOAc in PE, Rf 0.2.
is A small portion of the selectride reduction product obtained in the earlier step was purified by flash chromatography using silicagel (60 gm, 200-400 mesh). The desired product was obtained in pet ether-30% EtOAc eluate: Rg 0.2 (solvent system pet.ether-20%
EtOAc). 1H
NMR (CDCI3): S 0.05 (s,6H); 0.8-0.9 (m, 12H); 1.2-1.6 (m, lOH); 1.7-1.9 (m, 3H); 2.I-2.3 30 (m, lOH); 2.4 (t, 2H J = 7.4 Hz); 3.65 (s, 3H); 3.9-4.0 (bs, 1H); 4.2-4.3 (bs, 1H); 5.3-5.5 (m, 2H).
Procedure: To a precooled 250 ml r.b. flask with a septum inlet and a magnetic stirring bar was added the crude selectride reduced product ( 13.52 gm) and THF
(anhydrous, 35 ss ml). The solution was cooled to 0°C and to this was added a solution of tetra-n-butyl ammonium flouride (30 mmols, 30 ml of 1M soln. In THF, 3 equiv.) dropwise by means of a syringe over a period of 5 min. Stirring was continued for 0.5 hr. at OPC
and 5 hr. at room temperature until the completion of reaction by TLC analysis (solvent system:
EtOAc). THF was removed in vacao and water (20m1 ) was added, extracted with EtOAc (3 x 30m1). The combined EtOAC layer was washed with water (2 x 10 ml), brine (2 x s lOml) and dried over anhydrous Na2S04. Concentration in vacuo afforded 5.409 gm of the crude product. This was further purified by flash chromatography over a column of silica gel (350 gm, 200-40(? mesh). The desired product was obtained in EtOAc eluate as a pale brown oiI ( 1.94 gm, 5.10 mmols), 51 % yield based on the starting (R) eonone:
Rf 0.5 (solvent system EtOAc). This was dissolved in anhydrous ethyl acetate (50 ml) and to this io was added 0.400 gm of the activated charcoal and stirred in an atmosphere of nitrogen at RT for 1 hr. This solution was filtered over celite bed using a G-4 sintered funnel, washed with EtOAc (30 ml): Removal of volatiles in vacuo afforded 1.95 gm of the crude product, which was purified by flash chromatography over a column of silica gel ( 150 gm, 200-400 mesh) and the desired product was obtained in ethyl acetate eluate as a colourless viscous ~s oil, which solidified on storing at -22°C as a colourless solid (chloroform-methanol gradient system can also be used for the flash chromatographic purification).
Yield: 1.90 gm, 5 mmols 50%. 1H NMR (CDCI3): 8 0.85 (t, 3H, J = 6.8 Hz); 1.1-1.5 (m, 8H);
1.6-1.9 (m, 7H); 2.1-2.5 (m, lOH); 3.65 (s, 3H); 3.85-4.0 (bs, 1H); 4.3-4.4 (bs, 1H) 5.3-5.6 (m, 2H): 13C NMR (CDCI3): 8 173.64, 139.50, 127.92, 79.56, 79.48, 77.2, 72.28, 72.02, 20 54.53, 51.4, 48.84, 42.56, 42.0, 32.69, 32.0 26.51, 23.87, 23.68, 22.35, 17.98, 16,97 and 13.78.
Note For the desilylation reaction it is essential to use anhydrous TBAF in THF. Use of TBAF.3 H20 does not give the desired product in good yield.
Preparation of carboprost methyl ester, (15S)-15- Methyl PGFZa methyl ester or IUPAC nomenclature as mentioned in USP as Prosta-5,13-diem-1-oic methyl ester, 9,11,15-trihydroxy-15-methyl-(5Z,9a,11a,13E,15S) or (Z)-7-[1R,2R,3R,SS)-3-5-Dihydroxy-2-[(E)-(3S)-3-hydroxy-3-methyl-1-octenyl]cyclopentyl]-5-heptenoic methyl 3o ester.
Selective Lindlar hydrogenation was performed in batches of 0.500 gm up to 1 gm scale.
The following procedure is representative.
3s A precooled 2-necked 1000 ml r.b. flask was charged with the desilylated product ( 1.065 gm, 2.80 mmols) and to this was added a preformed mixture of benzene ( 100 ml) and cyclohexane (300 ml) by means of a cannula under nitrogen. To the reaction mixture was added 0.315 gm of Pd over CaC03 poisoned with lead under nitrogen. The reaction mixture was evacuated in vacuo and flushed with hydrogen gas and through the reaction mixture was bubbled hydrogen gas while stirring at a rate of 45 bubbles per minute over a s period of 90 min: An aliquot was taken out at regular time intervals and the progress of the reaction was monitored by 13C NMR analysis (approx. 1.5 hrs, 13C NMR analysis should indicate the total disappearance of alkynyl carbon at 8 80 ppm). The reaction mixture was filtered using a G-4 sintered funnel, the residue washed with EtOAc. (The catalyst recovered could be recycled). Concentration of the organic phase in vacuo furnished the ~o desired carbonprost methyl ester as a viscous colourless oil ( lg). This was further purified by chromatography over silica gel in EtOAc eluate (chloroform-methanol gradient system can also be used for the flash chromatographic purification). 1H NMR (CDCI3 :
8 0.85 (t, 3H, J ~ 6.8 Hz); 1.1-1.5 (m, 8H); 1.6-1.9 (m, 7H); 2.1-2.5 (m, lOH); 3.65 (s, 3H); 3.85-4.0 (bs, 1H); 4.3-4.4 (bs, 1H); 5.3-5.6 (m, 4H): 13C NMR (CDCI3): 8 173.79, 139.0, 129.26, is 129.0, 128.5, 77.9, 72.6, 72.5, 55.6, 51.4, 50.4, 42.58, 33.16, 32.03, 27.23, 26.33, 25.29, 24.55, 23.62, 22.4 and 13.82.
This product was further purified by preparative reversed phase HPLC using a preparative ODS (C-18) SHIMPAK column (20 x 250 mm) and using a mobile phase of acetonitrite-2o water ( 1:1 ): UV detection: 210 nm. The preparative HPLC was done in batches of 0.170 gm and the recovery of the pure carbonprost methyl ester of USP specifications was --65%.
Claims (9)
1. A process for the preparation of a compound of formula (I):
in which R is CH=CH or CH2CH2, and R1 and R2 are both hydrogen or together form a bond, which comprises coupling a compound of formula (II);
in which R is as defined in formula (I) and P is a protecting group, with a compound of formula (III):
in which P1 is a protecting group and M is a cuprate to give a compound of formula (IA):
in which P and P1 are as defined above, and there after in any order:
~ optionally reducing the compound (IA) ~ removing any protecting groups.
in which R is CH=CH or CH2CH2, and R1 and R2 are both hydrogen or together form a bond, which comprises coupling a compound of formula (II);
in which R is as defined in formula (I) and P is a protecting group, with a compound of formula (III):
in which P1 is a protecting group and M is a cuprate to give a compound of formula (IA):
in which P and P1 are as defined above, and there after in any order:
~ optionally reducing the compound (IA) ~ removing any protecting groups.
2. A process according to claim 1 in which R is CH=CH.
3. A process according to claim 1 or 2 in which R1 and R2 are both hydrogen.
4. A process according to any one of claims 1 to 3 in which P is TBDMS and P1 is TMS.
5. A process according to any one of claims 1 to 4 in which hydrogenation of the triple bond of the compound of formula (IA) is carried out using Lindlar hydrogenation.
6. A process according to any one of claims 1 to 4 in which reduction of the cyclopentanone of the compound of formula (IA) is carried out using K-selectride.
7. A compound of formula (I) prepared according to the process of claims 1 to 6.
8. A compound of formula (1A):
in which P, P1 and R are as defined in claim 1.
in which P, P1 and R are as defined in claim 1.
9. A compound according to claim 8 in which R is CH=CH, P is TBDMS and P1 is TMS.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN465/MAS/98 | 1998-03-06 | ||
IN465MA1998 | 1998-03-06 | ||
SE9801369A SE9801369D0 (en) | 1998-04-20 | 1998-04-20 | Novel process |
SE9801369-1 | 1998-04-20 | ||
PCT/SE1999/000318 WO1999044990A1 (en) | 1998-03-06 | 1999-03-04 | Novel process |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2327332A1 true CA2327332A1 (en) | 1999-09-10 |
Family
ID=26324795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002327332A Abandoned CA2327332A1 (en) | 1998-03-06 | 1999-03-04 | Novel process |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1075464A1 (en) |
JP (1) | JP2002505321A (en) |
KR (1) | KR20010041632A (en) |
CN (1) | CN1292780A (en) |
AU (1) | AU2757299A (en) |
BR (1) | BR9908511A (en) |
CA (1) | CA2327332A1 (en) |
HU (1) | HUP0102710A2 (en) |
WO (1) | WO1999044990A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100437873B1 (en) * | 2001-05-08 | 2004-06-26 | 연성정밀화학(주) | Process for preparing prostaglandin derivatives and stereospecific starting material thereof |
CN102336693B (en) * | 2010-07-21 | 2014-01-22 | 上海天伟生物制药有限公司 | Carboprost tromethamine crystals, preparation method and application thereof |
CN102816099A (en) * | 2011-06-09 | 2012-12-12 | 上海天伟生物制药有限公司 | High-purity carboprost tromethamine, and preparation method and application thereof |
CN104860860B (en) * | 2015-04-29 | 2017-09-19 | 东北制药集团股份有限公司 | A kind of method for preparing purified of card prostatitis ester |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3728382A (en) * | 1970-05-04 | 1973-04-17 | Upjohn Co | 15-methyl and 15-ethyl prostaglandin analogs |
US3822303A (en) * | 1971-10-19 | 1974-07-02 | E Yankee | Trimethyl silyl esters of prostaglandin e acids and esters and process therefor |
GB1384024A (en) * | 1972-04-14 | 1974-02-12 | Searle & Co | Process for the preparation of 3-hydroxy-2-3-hydroxy-1-octenyl- 5-oxocyclopentane-heptanoic acid and derivatives thereof |
US4029691A (en) * | 1974-05-01 | 1977-06-14 | The Upjohn Company | Prostaglandin A1 , analogs |
DE3571319D1 (en) * | 1984-10-08 | 1989-08-10 | Teijin Ltd | Process for producing 2,3-disubstituted -4-substituted cyclopentanones, enantiomorphs, or mixtures thereof |
US5447865A (en) * | 1992-06-10 | 1995-09-05 | Amprost Pharmaceutical, Inc. | Method of resolution of hydroxy substituted cyclopentanone enantiomers using lipase and lithium salt complexation |
-
1999
- 1999-03-04 CN CN998037257A patent/CN1292780A/en active Pending
- 1999-03-04 HU HU0102710A patent/HUP0102710A2/en unknown
- 1999-03-04 JP JP2000534534A patent/JP2002505321A/en active Pending
- 1999-03-04 EP EP99908058A patent/EP1075464A1/en not_active Withdrawn
- 1999-03-04 BR BR9908511-9A patent/BR9908511A/en not_active IP Right Cessation
- 1999-03-04 CA CA002327332A patent/CA2327332A1/en not_active Abandoned
- 1999-03-04 KR KR1020007009831A patent/KR20010041632A/en not_active Application Discontinuation
- 1999-03-04 AU AU27572/99A patent/AU2757299A/en not_active Abandoned
- 1999-03-04 WO PCT/SE1999/000318 patent/WO1999044990A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20010041632A (en) | 2001-05-25 |
JP2002505321A (en) | 2002-02-19 |
CN1292780A (en) | 2001-04-25 |
HUP0102710A2 (en) | 2001-12-28 |
WO1999044990A1 (en) | 1999-09-10 |
BR9908511A (en) | 2000-11-21 |
AU2757299A (en) | 1999-09-20 |
EP1075464A1 (en) | 2001-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2099814A (en) | 15-deoxy-16-hydroxy prostaglandins | |
CN115010692A (en) | Design, preparation and application of novel macrolides | |
Iqbal et al. | Synthesis of Δ12, 14-15-deoxy-PG-J1 methyl ester and epi-Δ12-15-deoxy-PG-J1 | |
JP6643308B2 (en) | Metal-catalyzed asymmetric 1,4-conjugate addition of vinyl boron compounds to 2-substituted-4-oxy-cyclopent-2-en-1-ones to yield prostaglandins and prostaglandin analogs | |
CA2327332A1 (en) | Novel process | |
TANAKA et al. | Synthesis of 7-thiaprostaglandin E1 congeners: potent inhibitors of platelet aggregation | |
US4841091A (en) | Process for producing 16-substituted prostaglandin es. | |
JPH10504321A (en) | Preparation of prostaglandins E1, E2 and their analogs using furyl copper reagent | |
CN105801533B (en) | A kind of key intermediate preparing limaprost and its application | |
JP2018529781A (en) | Method for total synthesis of Resolvin E1 | |
JP4153998B2 (en) | Method for producing prostaglandins | |
JP2839841B2 (en) | Process for producing prostaglandin E1s, and synthetic intermediate thereof | |
Arnold | Phosphoramidites as ligands for copper in catalytic asymmetric CC bond formation reactions with organozinc reagents | |
CZ20003234A3 (en) | Novel process | |
US4808734A (en) | 16-cycloalkyl-7-fluoro-prostacyclins | |
JP2713333B2 (en) | Isocarbacyclines and process for producing the same | |
KR920004190B1 (en) | Process for the preparation of 7-thiaprostaglandin e1 | |
Neumann et al. | Chiral [2H]‐Labelled Methylene Groups in Trienoic‐and Dienoic Fatty Acids: A Facile Approach via Asymmetric Epoxidation of [2H] Allyl Alcohols | |
US5206416A (en) | Isocarbacyclin derivative | |
US4464304A (en) | Vinyl Cyclopropyl compounds as precursors to fatty acid oxidation products | |
CN105801534B (en) | A kind of key intermediate preparing limaprost and its application | |
US5113014A (en) | Processes for preparing prostaglandins | |
JPH0680024B2 (en) | Method for producing isocarbacyclines | |
JPS62195358A (en) | Production of (5e)-prostaglandin e2 or such | |
JPH062695B2 (en) | Method for producing isocarbacyclines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |